Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Head and Neck Cancer

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 468 articles:
HTML format



Single Articles


    January 2021
  1. MATSUOKA Y, Al-Shareef H, Kogo M, Nakahara H, et al
    Effects of decreased Rac activity and malignant state on oral squamous cell carcinoma in vitro.
    PLoS One. 2021;16:e0212323.
    PubMed     Abstract available


  2. HE L, Zhao W, Xia Z, Su A, et al
    Comparative efficacy of different ultrasound-guided ablation for the treatment of benign thyroid nodules: Systematic review and network meta-analysis of randomized controlled trials.
    PLoS One. 2021;16:e0243864.
    PubMed     Abstract available


  3. CHIANG TE, Lin YC, Wu CT, Yang CY, et al
    Comparison of the accuracy of diagnoses of oral potentially malignant disorders with dysplasia by a general dental clinician and a specialist using the Taiwanese Nationwide Oral Mucosal Screening Program.
    PLoS One. 2021;16:e0244740.
    PubMed     Abstract available


  4. VERZA FA, Valente VB, Oliveira LK, Kayahara GM, et al
    Social isolation stress facilitates chemically induced oral carcinogenesis.
    PLoS One. 2021;16:e0245190.
    PubMed     Abstract available


  5. WANG C, Lin M, Zhong L, Tian C, et al
    The value of TI-RADS combined with superb microvascular imaging in distinguishing thyroid nodules: A protocol for systematic review and meta-analysis.
    PLoS One. 2021;16:e0245035.
    PubMed     Abstract available


  6. CHUANG FC, Wang CC, Chen JH, Hwang TZ, et al
    PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy.
    PLoS One. 2021;16:e0245715.
    PubMed     Abstract available


  7. CHAMBARA N, Liu SYW, Lo X, Ying M, et al
    Diagnostic performance evaluation of different TI-RADS using ultrasound computer-aided diagnosis of thyroid nodules: An experience with adjusted settings.
    PLoS One. 2021;16:e0245617.
    PubMed     Abstract available


  8. MOHAMMADI N, Alimohammadian M, Feizesani A, Poustchi H, et al
    The marginal causal effect of opium consumption on the upper gastrointestinal cancer death using parametric g-formula: An analysis of 49,946 cases in the Golestan Cohort Study, Iran.
    PLoS One. 2021;16:e0246004.
    PubMed     Abstract available


  9. MILANI V, Zara ALSA, da Silva EN, Cardoso LB, et al
    Direct healthcare costs of lip, oral cavity and oropharyngeal cancer in Brazil.
    PLoS One. 2021;16:e0246475.
    PubMed     Abstract available


  10. CHENG PC, Chang CM, Liao LJ, Cheng PW, et al
    The outcomes and decision-making process for neck lymph nodes with indeterminate fine-needle aspiration cytology.
    PLoS One. 2021;16:e0246437.
    PubMed     Abstract available


  11. WALLANDER K, Eisfeldt J, Lindblad M, Nilsson D, et al
    Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients.
    PLoS One. 2021;16:e0245488.
    PubMed     Abstract available


  12. EVEN C, Sagaon Teyssier L, Pointreau Y, Temam S, et al
    Factors associated with under-reporting of head and neck squamous cell carcinoma in cause-of-death records: A comparative study of two national databases in France from 2008 to 2012.
    PLoS One. 2021;16:e0246252.
    PubMed     Abstract available


  13. LIU CH, Chang JT, Lee TH, Chang PY, et al
    Total plaque score helps to determine follow-up strategy for carotid artery stenosis progression in head and neck cancer patients after radiation therapy.
    PLoS One. 2021;16:e0246684.
    PubMed     Abstract available


  14. HUTAJULU SH, Howdon D, Taroeno-Hariadi KW, Hardianti MS, et al
    Survival outcome and prognostic factors of patients with nasopharyngeal cancer in Yogyakarta, Indonesia: A hospital-based retrospective study.
    PLoS One. 2021;16:e0246638.
    PubMed     Abstract available


  15. SUN Z, Nyberg R, Wu Y, Bernard B, et al
    Developing an enhanced 7-color multiplex IHC protocol to dissect immune infiltration in human cancers.
    PLoS One. 2021;16:e0247238.
    PubMed     Abstract available


  16. NANNAPANENI S, Griffith CC, Magliocca KR, Chen W, et al
    Co-expression of fibroblast growth factor receptor 3 with mutant p53, and its association with worse outcome in oropharyngeal squamous cell carcinoma.
    PLoS One. 2021;16:e0247498.
    PubMed     Abstract available


  17. KUO CY, Lee CC, Lee YL, Liou SC, et al
    Visual light perceptions caused by medical linear accelerator: Findings of machine-learning algorithms in a prospective questionnaire-based case-control study.
    PLoS One. 2021;16:e0247597.
    PubMed     Abstract available


  18. PAMPHLETT R, Doble PA, Bishop DP
    Mercury in the human thyroid gland: Potential implications for thyroid cancer, autoimmune thyroiditis, and hypothyroidism.
    PLoS One. 2021;16:e0246748.
    PubMed     Abstract available


  19. AL-SALAM S, Sharma C, Abu Sa'a MT, Afandi B, et al
    Ultrasound-guided fine needle aspiration cytology and ultrasound examination of thyroid nodules in the UAE: A comparison.
    PLoS One. 2021;16:e0247807.
    PubMed     Abstract available


    January 2020
  20. LEE JM, Park YM, Yun JS, Ahn YB, et al
    The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study.
    PLoS One. 2020;15:e0226351.
    PubMed     Abstract available


  21. NIU K, Guo C, Teng S, Zhou D, et al
    Pepsin promotes laryngopharyngeal neoplasia by modulating signaling pathways to induce cell proliferation.
    PLoS One. 2020;15:e0227408.
    PubMed     Abstract available


  22. PARK VY, Han K, Kim HJ, Lee E, et al
    Radiomics signature for prediction of lateral lymph node metastasis in conventional papillary thyroid carcinoma.
    PLoS One. 2020;15:e0227315.
    PubMed     Abstract available


  23. BJERKLI IH, Jetlund O, Karevold G, Karlsdottir A, et al
    Characteristics and prognosis of primary treatment-naive oral cavity squamous cell carcinoma in Norway, a descriptive retrospective study.
    PLoS One. 2020;15:e0227738.
    PubMed     Abstract available


  24. LEVY HC, Hulvey D, Adamson-Small L, Jn-Simon N, et al
    Improved cell-specificity of adeno-associated viral vectors for medullary thyroid carcinoma using calcitonin gene regulatory elements.
    PLoS One. 2020;15:e0228005.
    PubMed     Abstract available


  25. JENG MJ, Sharma M, Chao TY, Li YC, et al
    Multiclass classification of autofluorescence images of oral cavity lesions based on quantitative analysis.
    PLoS One. 2020;15:e0228132.
    PubMed     Abstract available


  26. NGUYEN CTK, Sawangarun W, Mandasari M, Morita KI, et al
    AIRE is induced in oral squamous cell carcinoma and promotes cancer gene expression.
    PLoS One. 2020;15:e0222689.
    PubMed     Abstract available


  27. EVERS C, Ostheimer C, Sieker F, Vordermark D, et al
    Benefit from surgery with additional radiotherapy in N1 head and neck cancer at the time of IMRT: A population-based study on recent developments.
    PLoS One. 2020;15:e0229266.
    PubMed     Abstract available


  28. PANG X, Fan HY, Tang YL, Wang SS, et al
    Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma.
    PLoS One. 2020;15:e0229089.
    PubMed     Abstract available


  29. CAO H, He Q, Eyben RV, Bloomstein J, et al
    The role of Glial cell derived neurotrophic factor in head and neck cancer.
    PLoS One. 2020;15:e0229311.
    PubMed     Abstract available


  30. NAIR S, Trummell HQ, Rajbhandari R, Thudi NK, et al
    Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer.
    PLoS One. 2020;15:e0229077.
    PubMed     Abstract available


  31. O'KEEFE RA, Bhola NE, Lee DS, Johnson DE, et al
    Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance.
    PLoS One. 2020;15:e0227261.
    PubMed     Abstract available


  32. RICHARD MA, Lupo PJ, Morton LM, Yasui YA, et al
    Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.
    PLoS One. 2020;15:e0228887.
    PubMed     Abstract available


  33. TCHEANDJIEU C, Cordina-Duverger E, Mulot C, Baron-Dubourdieu D, et al
    Role of GSTM1 and GSTT1 genotypes in differentiated thyroid cancer and interaction with lifestyle factors: Results from case-control studies in France and New Caledonia.
    PLoS One. 2020;15:e0228187.
    PubMed     Abstract available


  34. FADHIL RS, Wei MQ, Nikolarakos D, Good D, et al
    Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    PLoS One. 2020;15:e0221779.
    PubMed     Abstract available


  35. YOON JH, Han K, Lee E, Lee J, et al
    Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAFV600E mutations in papillary thyroid carcinoma.
    PLoS One. 2020;15:e0228968.
    PubMed     Abstract available


  36. MA F, Gu X, Liu JQ, Mo LH, et al
    Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells.
    PLoS One. 2020;15:e0229272.
    PubMed     Abstract available


  37. GONDHOWIARDJO SA, Handoko, Adham M, Rachmadi L, et al
    Tumor microenvironment predicts local tumor extensiveness in PD-L1 positive nasopharyngeal cancer.
    PLoS One. 2020;15:e0230449.
    PubMed     Abstract available


  38. VIDIRI A, Gangemi E, Ruberto E, Pasqualoni R, et al
    Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes.
    PLoS One. 2020;15:e0229611.
    PubMed     Abstract available


  39. WALCZYK A, Kopczynski J, Gasior-Perczak D, Palyga I, et al
    Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients.
    PLoS One. 2020;15:e0229264.
    PubMed     Abstract available


  40. AL-SALAM S, Sharma C, Afandi B, Al Dahmani K, et al
    BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.
    PLoS One. 2020;15:e0231341.
    PubMed     Abstract available


  41. HIRSHOREN N, Yoeli R, Cohen JE, Weinberger JM, et al
    Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients.
    PLoS One. 2020;15:e0231038.
    PubMed     Abstract available


  42. HOEFNAGEL SJM, Mostafavi N, Timmer MR, Lau CT, et al
    A genomic biomarker-based model for cancer risk stratification of non-dysplastic Barrett's esophagus patients after extended follow up; results from Dutch surveillance cohorts.
    PLoS One. 2020;15:e0231419.
    PubMed     Abstract available


  43. PLATEK A, Mix M, Chowdhry V, Farrugia M, et al
    Evaluation of radiation treatment volumes for unknown primaries of the head and neck in the era of FDG PET.
    PLoS One. 2020;15:e0231042.
    PubMed     Abstract available


  44. FREDERIKSEN K, Krag AE, Larsen JB, Kiil BJ, et al
    Remote ischemic preconditioning does not influence lectin pathway protein levels in head and neck cancer patients undergoing surgery.
    PLoS One. 2020;15:e0230411.
    PubMed     Abstract available


  45. IBUKI Y, Nishiyama Y, Tsutani Y, Emi M, et al
    Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma.
    PLoS One. 2020;15:e0231116.
    PubMed     Abstract available


  46. BHALLA S, Kaur H, Kaur R, Sharma S, et al
    Expression based biomarkers and models to classify early and late-stage samples of Papillary Thyroid Carcinoma.
    PLoS One. 2020;15:e0231629.
    PubMed     Abstract available


  47. ZHANG J, Zhang X, Meng Y, Chen Y, et al
    Contrast-enhanced ultrasound for the differential diagnosis of thyroid nodules: An updated meta-analysis with comprehensive heterogeneity analysis.
    PLoS One. 2020;15:e0231775.
    PubMed     Abstract available


  48. YOSHIDA R, Nagata M, Hirosue A, Kawahara K, et al
    Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method.
    PLoS One. 2020;15:e0231656.
    PubMed     Abstract available


  49. JUNG HK, Tae CH, Lee HA, Lee H, et al
    Treatment pattern and overall survival in esophageal cancer during a 13-year period: A nationwide cohort study of 6,354 Korean patients.
    PLoS One. 2020;15:e0231456.
    PubMed     Abstract available


  50. PEROT P, Falguieres M, Arowas L, Laude H, et al
    Investigation of viral etiology in potentially malignant disorders and oral squamous cell carcinomas in non-smoking, non-drinking patients.
    PLoS One. 2020;15:e0232138.
    PubMed     Abstract available


  51. MATSUDA S, Mafune A, Kohda N, Hama T, et al
    Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma.
    PLoS One. 2020;15:e0231932.
    PubMed     Abstract available


  52. HAN B, Yang X, Zhang P, Zhang Y, et al
    DNA methylation biomarkers for nasopharyngeal carcinoma.
    PLoS One. 2020;15:e0230524.
    PubMed     Abstract available


  53. LI S, Peng L, Tan C, Zeng X, et al
    Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China.
    PLoS One. 2020;15:e0232240.
    PubMed     Abstract available


  54. LOPETUSO LR, Severgnini M, Pecere S, Ponziani FR, et al
    Esophageal microbiome signature in patients with Barrett's esophagus and esophageal adenocarcinoma.
    PLoS One. 2020;15:e0231789.
    PubMed     Abstract available


  55. HUANG CC, Lin YH, Kittipayak S, Hwua YS, et al
    Biokinetic model of radioiodine I-131 in nine thyroid cancer patients subjected to in-vivo gamma camera scanning: A simplified five-compartmental model.
    PLoS One. 2020;15:e0232480.
    PubMed     Abstract available


  56. DE SOUZA REIS R, Gatta G, de Camargo B
    Thyroid carcinoma in children, adolescents, and young adults in Brazil: A report from 11 population-based cancer registries.
    PLoS One. 2020;15:e0232416.
    PubMed     Abstract available


  57. KEEK S, Sanduleanu S, Wesseling F, de Roest R, et al
    Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
    PLoS One. 2020;15:e0232639.
    PubMed     Abstract available


  58. MENEZES FDS, Latorre MDRDO, Conceicao GMS, Curado MP, et al
    The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil.
    PLoS One. 2020;15:e0232871.
    PubMed     Abstract available


  59. KARSTENS KF, Kempski J, Giannou AD, Freiwald E, et al
    Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomas.
    PLoS One. 2020;15:e0231833.
    PubMed     Abstract available


  60. CHENG Y, Huang Z, Liao Q, Yu X, et al
    Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    PLoS One. 2020;15:e0232800.
    PubMed     Abstract available


  61. SANDBLOM V, Spetz J, Shubbar E, Montelius M, et al
    Increased therapeutic effect on medullary thyroid cancer using a combination of radiation and tyrosine kinase inhibitors.
    PLoS One. 2020;15:e0233720.
    PubMed     Abstract available


  62. SAKAI A, Ando M, Fukusumi T, Ren S, et al
    Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing.
    PLoS One. 2020;15:e0233380.
    PubMed     Abstract available


  63. SUBHI O, Schulten HJ, Bagatian N, Al-Dayini R, et al
    Genetic relationship between Hashimoto`s thyroiditis and papillary thyroid carcinoma with coexisting Hashimoto`s thyroiditis.
    PLoS One. 2020;15:e0234566.
    PubMed     Abstract available


  64. DICKINSON A, Saraswat M, Syrjanen S, Tohmola T, et al
    Comparing serum protein levels can aid in differentiating HPV-negative and -positive oropharyngeal squamous cell carcinoma patients.
    PLoS One. 2020;15:e0233974.
    PubMed     Abstract available


  65. SINGH R, Das S, Datta S, Mazumdar A, et al
    Study of Caspase 8 mutation in oral cancer and adjacent precancer tissues and implication in progression.
    PLoS One. 2020;15:e0233058.
    PubMed     Abstract available


  66. DALHAMMAR K, Malmstrom M, Schelin M, Falkenback D, et al
    The impact of initial treatment strategy and survival time on quality of end-of-life care among patients with oesophageal and gastric cancer: A population-based cohort study.
    PLoS One. 2020;15:e0235045.
    PubMed     Abstract available


  67. ORTIZ-COMINO L, Fernandez-Lao C, Speksnijder CM, Lozano-Lozano M, et al
    Upper body motor function and swallowing impairments and its association in survivors of head and neck cancer: A cross-sectional study.
    PLoS One. 2020;15:e0234467.
    PubMed     Abstract available


  68. PARK KA, Eum SY, Oh H, Cho MH, et al
    Factors affecting online health community participation behavior in patients with thyroid cancer.
    PLoS One. 2020;15:e0235056.
    PubMed     Abstract available


  69. WANG X, Zhu J, Li Z, Wei T, et al
    The benefits of radioactive iodine ablation for patients with intermediate-risk papillary thyroid cancer.
    PLoS One. 2020;15:e0234843.
    PubMed     Abstract available


  70. YANG CY, Tsao CH, Hsieh CC, Lin CK, et al
    Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model.
    PLoS One. 2020;15:e0236101.
    PubMed     Abstract available


  71. SHI S, Huang X, Ma X, Zhu X, et al
    Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells.
    PLoS One. 2020;15:e0225290.
    PubMed     Abstract available


  72. ZSCHAECK S, Li Y, Lin Q, Beck M, et al
    Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
    PLoS One. 2020;15:e0236841.
    PubMed     Abstract available


  73. WU ZH, Fang M, Zhou Y
    Comprehensive analysis of the expression and prognosis for CDCAs in head and neck squamous cell carcinoma.
    PLoS One. 2020;15:e0236678.
    PubMed     Abstract available


  74. GARMAN KS, Ajayi TA, Boutte HJ Jr, Chiu ST, et al
    Prior tonsillectomy is associated with an increased risk of esophageal adenocarcinoma.
    PLoS One. 2020;15:e0235906.
    PubMed     Abstract available


  75. KALISZEWSKI K, Diakowska D, Wojtczak B, Rudnicki J, et al
    Cancer screening activity results in overdiagnosis and overtreatment of papillary thyroid cancer: A 10-year experience at a single institution.
    PLoS One. 2020;15:e0236257.
    PubMed     Abstract available


  76. KOIKE K, Dehari H, Ogi K, Shimizu S, et al
    Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma.
    PLoS One. 2020;15:e0237465.
    PubMed     Abstract available


  77. WITKIEWICZ J, Klimza H, Piersiala K, Jackowska J, et al
    The usefulness of the narrow band imaging (NBI) in decision-making process regarding second look procedure (SL) in laryngeal cancer follow-up after transoral laser microsurgery.
    PLoS One. 2020;15:e0236623.
    PubMed     Abstract available


  78. LIN FC, Chang WL, Chiang NJ, Lin MY, et al
    Radiation dose escalation can improve local disease control and survival among esophageal cancer patients with large primary tumor volume receiving definitive chemoradiotherapy.
    PLoS One. 2020;15:e0237114.
    PubMed     Abstract available


  79. CHEN YH, Lin CR, Liang WA, Huang CY, et al
    Motor control integrated into muscle strengthening exercises has more effects on scapular muscle activities and joint range of motion before initiation of radiotherapy in oral cancer survivors with neck dissection: A randomized controlled trial.
    PLoS One. 2020;15:e0237133.
    PubMed     Abstract available


  80. THOMAS S, Carroll JC, Brown MC, Chen Z, et al
    Nicotine dependence as a risk factor for upper aerodigestive tract (UADT) cancers: A mediation analysis.
    PLoS One. 2020;15:e0237723.
    PubMed     Abstract available


  81. LIN NC, Hsu JT, Tsai KY
    Survival and clinicopathological characteristics of different histological grades of oral cavity squamous cell carcinoma: A single-center retrospective study.
    PLoS One. 2020;15:e0238103.
    PubMed     Abstract available


  82. YOON JH, Jeon MJ, Kim M, Hong AR, et al
    Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea.
    PLoS One. 2020;15:e0238207.
    PubMed     Abstract available


  83. SAKAI A, Tagami M, Kakehashi A, Katsuyama-Yoshikawa A, et al
    Expression, intracellular localization, and mutation of EGFR in conjunctival squamous cell carcinoma and the association with prognosis and treatment.
    PLoS One. 2020;15:e0238120.
    PubMed     Abstract available


  84. ANWAR N, Pervez S, Chundriger Q, Awan S, et al
    Oral cancer: Clinicopathological features and associated risk factors in a high risk population presenting to a major tertiary care center in Pakistan.
    PLoS One. 2020;15:e0236359.
    PubMed     Abstract available


  85. SABA NF, Dinasarapu AR, Magliocca KR, Dwivedi B, et al
    Signatures of somatic mutations and gene expression from p16INK4A positive head and neck squamous cell carcinomas (HNSCC).
    PLoS One. 2020;15:e0238497.
    PubMed     Abstract available


  86. ZHANG W, Xu S, Shi L, Zhu Z, et al
    Construction and analysis of a competing endogenous RNA network to reveal potential prognostic biomarkers for Oral Floor Squamous Cell Carcinoma.
    PLoS One. 2020;15:e0238420.
    PubMed     Abstract available


  87. KIM GH, Min YW, Lee H, Min BH, et al
    Risk factors of metachronous recurrence after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma.
    PLoS One. 2020;15:e0238113.
    PubMed     Abstract available


  88. GUERREIRO EM, Ovstebo R, Thiede B, Costea DE, et al
    Cancer cell line-specific protein profiles in extracellular vesicles identified by proteomics.
    PLoS One. 2020;15:e0238591.
    PubMed     Abstract available


  89. VAN HINTE G, Leijendekkers RA, Te Molder B, Jansen L, et al
    Reproducibility of measurements on physical performance in head and neck cancer survivors; measurements on maximum mouth opening, shoulder and neck function, upper and lower body strength, level of physical mobility, and walking ability.
    PLoS One. 2020;15:e0233271.
    PubMed     Abstract available


  90. PINTO N, Prokopec SD, Ghasemi F, Meens J, et al
    Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models.
    PLoS One. 2020;15:e0239315.
    PubMed     Abstract available


  91. ZENG S, Fu L, Zhou P, Ling H, et al
    Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0239586.
    PubMed     Abstract available


  92. BJERKLI IH, Laurvik H, Nginamau ES, Soland TM, et al
    Tumor budding score predicts lymph node status in oral tongue squamous cell carcinoma and should be included in the pathology report.
    PLoS One. 2020;15:e0239783.
    PubMed     Abstract available


  93. AKRAM F, Koh PE, Wang F, Zhou S, et al
    Exploring MRI based radiomics analysis of intratumoral spatial heterogeneity in locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy.
    PLoS One. 2020;15:e0240043.
    PubMed     Abstract available


  94. RZEPAKOWSKA A, Zurek M, Grzybowski J, Kotula I, et al
    Serum and tissue expression of neuropilin 1 in precancerous and malignant vocal fold lesions.
    PLoS One. 2020;15:e0239550.
    PubMed     Abstract available


  95. PORTO AC, Pinto Blumetti T, Oliveira Santos Filho IDA, Calsavara VF, et al
    Primary cutaneous melanoma of the scalp: Patterns of clinical, histological and epidemiological characteristics in Brazil.
    PLoS One. 2020;15:e0240864.
    PubMed     Abstract available


  96. SANIKINI H, Muller DC, Chadeau-Hyam M, Murphy N, et al
    Anthropometry, body fat composition and reproductive factors and risk of oesophageal and gastric cancer by subtype and subsite in the UK Biobank cohort.
    PLoS One. 2020;15:e0240413.
    PubMed     Abstract available


  97. BRADLEY A, Sami S, N G H, Macleod A, et al
    A predictive Bayesian network that risk stratifies patients undergoing Barrett's surveillance for personalized risk of developing malignancy.
    PLoS One. 2020;15:e0240620.
    PubMed     Abstract available


  98. WONG WY, Gilman K, Limesand KH
    Yap activation in irradiated parotid salivary glands is regulated by ROCK activity.
    PLoS One. 2020;15:e0232921.
    PubMed     Abstract available


  99. NA HY, Moon JH, Choi JY, Yu HW, et al
    Preoperative diagnostic categories of fine needle aspiration cytology for histologically proven thyroid follicular adenoma and carcinoma, and Hurthle cell adenoma and carcinoma: Analysis of cause of under- or misdiagnoses.
    PLoS One. 2020;15:e0241597.
    PubMed     Abstract available


  100. RAMASAMY T, Chen X, Qin B, Johnson DE, et al
    STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors.
    PLoS One. 2020;15:e0242264.
    PubMed     Abstract available


  101. XU S, Li Z, Xu M, Peng H, et al
    The role of carbon nanoparticle in lymph node detection and parathyroid gland protection during thyroidectomy for non-anaplastic thyroid carcinoma- a meta-analysis.
    PLoS One. 2020;15:e0223627.
    PubMed     Abstract available


  102. YOON J, Lee E, Koo JS, Yoon JH, et al
    Artificial intelligence to predict the BRAFV600E mutation in patients with thyroid cancer.
    PLoS One. 2020;15:e0242806.
    PubMed     Abstract available


  103. MUKHERJEE G, Bag S, Chakraborty P, Dey D, et al
    Density of CD3+ and CD8+ cells in gingivo-buccal oral squamous cell carcinoma is associated with lymph node metastases and survival.
    PLoS One. 2020;15:e0242058.
    PubMed     Abstract available


  104. WONDIMAGEGNEHU A, Hirpa S, Abaya SW, Gizaw M, et al
    Oesophageal cancer magnitude and presentation in Ethiopia 2012-2017.
    PLoS One. 2020;15:e0242807.
    PubMed     Abstract available


  105. YKEMA BLM, Hoefnagel SJM, Rigter LS, Kodach LL, et al
    Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases.
    PLoS One. 2020;15:e0243178.
    PubMed     Abstract available


  106. CHUERDUANGPHUI J, Ekalaksananan T, Heawchaiyaphum C, Vatanasapt P, et al
    Peroxiredoxin 2 is highly expressed in human oral squamous cell carcinoma cells and is upregulated by human papillomavirus oncoproteins and arecoline, promoting proliferation.
    PLoS One. 2020;15:e0242465.
    PubMed     Abstract available


  107. OFFICER K, Pruvot M, Horwood P, Denk D, et al
    Epidemiology and pathological progression of erythematous lip lesions in captive sun bears (Helarctos malayanus).
    PLoS One. 2020;15:e0243180.
    PubMed     Abstract available


  108. MU HW, Chen CH, Yang KW, Pan CS, et al
    The prevalence of esophageal cancer after caustic and pesticide ingestion: A nationwide cohort study.
    PLoS One. 2020;15:e0243922.
    PubMed     Abstract available


  109. UCHIDA Y, Tsugawa T, Tanaka-Mizuno S, Noma K, et al
    Prediction of radiation pneumonitis using dose-volume histogram parameters with high attenuation in two types of cancer: A retrospective study.
    PLoS One. 2020;15:e0244143.
    PubMed     Abstract available


  110. DANSTRUP CS, Marcussen M, Pedersen IS, Jacobsen H, et al
    DNA methylation biomarkers in peripheral blood of patients with head and neck squamous cell carcinomas. A systematic review.
    PLoS One. 2020;15:e0244101.
    PubMed     Abstract available


  111. KANG SK, Mali RD, Braithwaite RS, Kerr AR, et al
    Point-of-care characterization and risk-based management of oral lesions in primary dental clinics: A simulation model.
    PLoS One. 2020;15:e0244446.
    PubMed     Abstract available


  112. PARK JM, Choi CH, Wu HG, Kim JI, et al
    Correlation of the gamma passing rates with the differences in the dose-volumetric parameters between the original VMAT plans and actual deliveries of the VMAT plans.
    PLoS One. 2020;15:e0244690.
    PubMed     Abstract available


  113. KALISZEWSKI K, Diakowska D, Rzeszutko M, Nowak L, et al
    Risk factors of papillary thyroid microcarcinoma that predispose patients to local recurrence.
    PLoS One. 2020;15:e0244930.
    PubMed     Abstract available


    January 2019
  114. GOMEZ-ARMAYONES S, Chimenos-Kustner E, Mari A, Tous S, et al
    Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanish cohort.
    PLoS One. 2019;14:e0210070.
    PubMed     Abstract available


  115. HUANG YC, Li SH, Lu HI, Hsu CC, et al
    Post-chemoradiotherapy FDG PET with qualitative interpretation criteria for outcome stratification in esophageal squamous cell carcinoma.
    PLoS One. 2019;14:e0210055.
    PubMed     Abstract available


  116. CUMMINGS III KC, Kou TD, Chak A, Schluchter MD, et al
    Surgical approach and the impact of epidural analgesia on survival after esophagectomy for cancer: A population-based retrospective cohort study.
    PLoS One. 2019;14:e0211125.
    PubMed     Abstract available


  117. YOKOYAMA A, Yokoyama T, Omori T, Maesato H, et al
    Endoscopic screening using esophageal iodine staining and genotypes of ADH1B and ALDH2 in Japanese alcohol-dependent women.
    PLoS One. 2019;14:e0210546.
    PubMed     Abstract available


  118. JIMENEZ-ORTEGA E, Ureba A, Baeza JA, Barbeiro AR, et al
    Accurate, robust and harmonized implementation of morpho-functional imaging in treatment planning for personalized radiotherapy.
    PLoS One. 2019;14:e0210549.
    PubMed     Abstract available


  119. ZHU X, Luo X, Feng G, Huang H, et al
    CENPE expression is associated with its DNA methylation status in esophageal adenocarcinoma and independently predicts unfavorable overall survival.
    PLoS One. 2019;14:e0207341.
    PubMed     Abstract available


  120. DENARO M, Navari E, Ugolini C, Seccia V, et al
    A microRNA signature for the differential diagnosis of salivary gland tumors.
    PLoS One. 2019;14:e0210968.
    PubMed     Abstract available


  121. CHUNG CM, Hung CC, Lee CH, Lee CP, et al
    Variants in FAT1 and COL9A1 genes in male population with or without substance use to assess the risk factors for oral malignancy.
    PLoS One. 2019;14:e0210901.
    PubMed     Abstract available


  122. SABARIMURUGAN S, Kumarasamy C, Baxi S, Devi A, et al
    Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma.
    PLoS One. 2019;14:e0209760.
    PubMed     Abstract available


  123. BOZINOVIC K, Sabol I, Rakusic Z, Jakovcevic A, et al
    HPV-driven oropharyngeal squamous cell cancer in Croatia - Demography and survival.
    PLoS One. 2019;14:e0211577.
    PubMed     Abstract available


  124. OWONIKOKO TK, Zhang G, Lallani SB, Chen Z, et al
    Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models.
    PLoS One. 2019;14:e0206309.
    PubMed     Abstract available


  125. FURNERI G, Klausnitzer R, Haycock L, Ihara Z, et al
    Economic value of narrow-band imaging versus white light endoscopy for the diagnosis and surveillance of Barrett's esophagus: Cost-consequence model.
    PLoS One. 2019;14:e0212916.
    PubMed     Abstract available


  126. NEMETH CG, Rocken C, Siebert R, Wiltfang J, et al
    Recurrent chromosomal and epigenetic alterations in oral squamous cell carcinoma and its putative premalignant condition oral lichen planus.
    PLoS One. 2019;14:e0215055.
    PubMed     Abstract available


  127. KIM DK, Kim EK, Jung DW, Kim J, et al
    Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts.
    PLoS One. 2019;14:e0214553.
    PubMed     Abstract available


  128. GUEZENNEC C, Bourhis D, Orlhac F, Robin P, et al
    Inter-observer and segmentation method variability of textural analysis in pre-therapeutic FDG PET/CT in head and neck cancer.
    PLoS One. 2019;14:e0214299.
    PubMed     Abstract available


  129. GRISANTI S, Bianchi S, Locati LD, Triggiani L, et al
    Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events.
    PLoS One. 2019;14:e0213934.
    PubMed     Abstract available


  130. HSING EW, Shiah SG, Peng HY, Chen YW, et al
    TNF-alpha-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility.
    PLoS One. 2019;14:e0213463.
    PubMed     Abstract available


  131. MACEDO LT, Ferrari VE, Carron J, Costa EFD, et al
    Cost-minimization analysis of GSTP1c.313A>G genotyping for the prevention of cisplatin-induced nausea and vomiting: A Bayesian inference approach.
    PLoS One. 2019;14:e0213929.
    PubMed     Abstract available


  132. KROENKE M, Hirata K, Gafita A, Watanabe S, et al
    Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer.
    PLoS One. 2019;14:e0213111.
    PubMed     Abstract available


  133. DZINIC SH, Mahdi Z, Bernardo MM, Vranic S, et al
    Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma.
    PLoS One. 2019;14:e0215089.
    PubMed     Abstract available


  134. RENZI A, De Bonis P, Morandi L, Lenzi J, et al
    Prevalence of p53 dysregulations in feline oral squamous cell carcinoma and non-neoplastic oral mucosa.
    PLoS One. 2019;14:e0215621.
    PubMed     Abstract available


  135. MEI M, Wang Y, Zhang M
    Causes of mortality in cases with extra nodal natural killer/T-cell lymphoma, nasal type: A cohort study.
    PLoS One. 2019;14:e0214860.
    PubMed     Abstract available


  136. DUNCAN DJ, Scott M, Scorer P, Barker C, et al
    Assessment of PD-L1 mRNA and protein expression in non-small cell lung cancer, head and neck squamous cell carcinoma and urothelial carcinoma tissue specimens using RNAScope and immunohistochemistry.
    PLoS One. 2019;14:e0215393.
    PubMed     Abstract available


  137. LEE JC, Chuang KS, Hsueh Liu YW, Lin TY, et al
    A comparison of dose distributions in gross tumor volume between boron neutron capture therapy alone and combined boron neutron capture therapy plus intensity modulation radiation therapy for head and neck cancer.
    PLoS One. 2019;14:e0210626.
    PubMed     Abstract available


  138. ECONOMOPOULOU P, Koutsodontis G, Avgeris M, Strati A, et al
    HPV16 E6/E7 expression in circulating tumor cells in oropharyngeal squamous cell cancers: A pilot study.
    PLoS One. 2019;14:e0215984.
    PubMed     Abstract available


  139. LEI K, He X, Yu L, Ni C, et al
    Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
    PLoS One. 2019;14:e0215948.
    PubMed     Abstract available


  140. BAI A, Liu X, Bielawski J, Hannun YA, et al
    Bioactive sphingolipid profile in a xenograft mouse model of head and neck squamous cell carcinoma.
    PLoS One. 2019;14:e0215770.
    PubMed     Abstract available


  141. BEICHEL RR, Ulrich EJ, Smith BJ, Bauer C, et al
    FDG PET based prediction of response in head and neck cancer treatment: Assessment of new quantitative imaging features.
    PLoS One. 2019;14:e0215465.
    PubMed     Abstract available


  142. LI Z, Jiang C, Yuan Y
    TCGA based integrated genomic analyses of ceRNA network and novel subtypes revealing potential biomarkers for the prognosis and target therapy of tongue squamous cell carcinoma.
    PLoS One. 2019;14:e0216834.
    PubMed     Abstract available


  143. KIM SH, Oh SA, Yea JW, Park JW, et al
    Prospective assessment of inter- or intra-fractional variation according to body weight or volume change in patients with head and neck cancer undergoing radiotherapy.
    PLoS One. 2019;14:e0216655.
    PubMed     Abstract available


  144. LIU L, Xie W, Xue P, Wei Z, et al
    Diagnostic accuracy and prognostic applications of CYFRA 21-1 in head and neck cancer: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0216561.
    PubMed     Abstract available


  145. LIU H, Zhao J, Fu R, Zhu C, et al
    The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway.
    PLoS One. 2019;14:e0216759.
    PubMed     Abstract available


  146. ZHOU J, Zhang J, Xu M, Ke Z, et al
    High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
    PLoS One. 2019;14:e0215299.
    PubMed     Abstract available


  147. PARK YJ, Kim JY, Lee DY, Zhang X, et al
    PKM2 enhances cancer invasion via ETS-1-dependent induction of matrix metalloproteinase in oral squamous cell carcinoma cells.
    PLoS One. 2019;14:e0216661.
    PubMed     Abstract available


  148. OSEI-SARFO K, Gudas LJ
    Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells.
    PLoS One. 2019;14:e0215234.
    PubMed     Abstract available


  149. GONDIVKAR SM, Gadbail AR, Sarode SC, Gondivkar RS, et al
    Measurement properties of oral health related patient reported outcome measures in patients with oral cancer: A systematic review using COSMIN checklist.
    PLoS One. 2019;14:e0218833.
    PubMed     Abstract available


  150. KANG SY, Bang JI, Kang KW, Lee HY, et al
    FDG PET/CT for the early prediction of RAI therapy response in patients with metastatic differentiated thyroid carcinoma.
    PLoS One. 2019;14:e0218416.
    PubMed     Abstract available


  151. LIU Z, Huang Y, Chen S, Hu D, et al
    Minimal extrathyroidal extension affects the prognosis of differentiated thyroid cancer: Is there a need for change in the AJCC classification system?
    PLoS One. 2019;14:e0218171.
    PubMed     Abstract available


  152. SOBTI A, Sharif-Askari FS, Khan S, Sharif-Askari NS, et al
    Logistic regression prediction model identify type 2 diabetes mellitus as a prognostic factor for human papillomavirus-16 associated head and neck squamous cell carcinoma.
    PLoS One. 2019;14:e0217000.
    PubMed     Abstract available


  153. REDDY RB, Khora SS, Suresh A
    Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma-A meta-analysis approach.
    PLoS One. 2019;14:e0218989.
    PubMed     Abstract available


  154. LEE HS, Lee JW, Park JH, Kim WS, et al
    Comprehensive analysis for diagnosis of preoperative non-invasive follicular thyroid neoplasm with papillary-like nuclear features.
    PLoS One. 2019;14:e0218046.
    PubMed     Abstract available


  155. STRAUB D, Oude Elferink RPJ, Jansen PLM, Bergman JJGHM, et al
    Glyco-conjugated bile acids drive the initial metaplastic gland formation from multi-layered glands through crypt-fission in a murine model.
    PLoS One. 2019;14:e0220050.
    PubMed     Abstract available


  156. DU T, Xiao J, Qiu Z, Wu K, et al
    The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0219611.
    PubMed     Abstract available


  157. HALCZY-KOWALIK L, Drozd A, Stachowska E, Drozd R, et al
    Fatty acids distribution and content in oral squamous cell carcinoma tissue and its adjacent microenvironment.
    PLoS One. 2019;14:e0218246.
    PubMed     Abstract available


  158. GER RB, Zhou S, Elgohari B, Elhalawani H, et al
    Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients.
    PLoS One. 2019;14:e0222509.
    PubMed     Abstract available


  159. BALTIN C, Kron F, Urbanski A, Zander T, et al
    The economic burden of endoscopic treatment for anastomotic leaks following oncological Ivor Lewis esophagectomy.
    PLoS One. 2019;14:e0221406.
    PubMed     Abstract available


  160. LIANG S, Gao Y, Liu Y, Qiu C, et al
    Contrast-enhanced Ultrasound in evaluating of angiogenesis and tumor staging of nasopharyngeal carcinoma in nude mice.
    PLoS One. 2019;14:e0221638.
    PubMed     Abstract available


  161. WANG B, Zhu CR, Liu H, Wu J, et al
    The effectiveness of parathyroid gland autotransplantation in preserving parathyroid function during thyroid surgery for thyroid neoplasms: A meta-analysis.
    PLoS One. 2019;14:e0221173.
    PubMed     Abstract available


  162. SILFVERSCHIOLD M, Sjovall J, Wennerberg J, Ostensson E, et al
    Societal cost of oropharyngeal cancer by human papillomavirus status, cancer stage, and subsite.
    PLoS One. 2019;14:e0220534.
    PubMed     Abstract available


  163. PLOYPETCH S, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, et al
    Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry.
    PLoS One. 2019;14:e0219390.
    PubMed     Abstract available


  164. WU H, Zhang B, Cai G, Li J, et al
    American College of Radiology thyroid imaging report and data system combined with K-RAS mutation improves the management of cytologically indeterminate thyroid nodules.
    PLoS One. 2019;14:e0219383.
    PubMed     Abstract available


  165. BRITT EL, Raman S, Leek K, Sheehy CH, et al
    Combination of fenretinide and ABT-263 induces apoptosis through NOXA for head and neck squamous cell carcinoma treatment.
    PLoS One. 2019;14:e0219398.
    PubMed     Abstract available


  166. OSADA AH, Endo K, Kimura Y, Sakamoto K, et al
    Addiction of mesenchymal phenotypes on the FGF/FGFR axis in oral squamous cell carcinoma cells.
    PLoS One. 2019;14:e0217451.
    PubMed     Abstract available


  167. LOPEZ-CEDRUN JL, Otero-Rico A, Vazquez-Mahia I, Seoane J, et al
    Association between hospital interval and survival in patients with oral cancer: A waiting time paradox.
    PLoS One. 2019;14:e0224067.
    PubMed     Abstract available


  168. CHENG W, Shen X, Xing M
    Decreased breast cancer-specific mortality risk in patients with a history of thyroid cancer.
    PLoS One. 2019;14:e0221093.
    PubMed     Abstract available


  169. CHOONOO G, Blucher AS, Higgins S, Boardman M, et al
    Illuminating biological pathways for drug targeting in head and neck squamous cell carcinoma.
    PLoS One. 2019;14:e0223639.
    PubMed     Abstract available


  170. TALANI C, Makitie A, Beran M, Holmberg E, et al
    Early mortality after diagnosis of cancer of the head and neck - A population-based nationwide study.
    PLoS One. 2019;14:e0223154.
    PubMed     Abstract available


  171. NI G, Huang K, Luan Y, Cao Z, et al
    Human papillomavirus infection among head and neck squamous cell carcinomas in southern China.
    PLoS One. 2019;14:e0221045.
    PubMed     Abstract available


  172. VAN HORN N, Faizy TD, Schoenfeld MH, Kohlmann P, et al
    Computed tomography findings in patients with primarily unknown causes of severe or recurrent epistaxis.
    PLoS One. 2019;14:e0220380.
    PubMed     Abstract available


  173. BELLMUNT AM, Lopez-Puerto L, Lorente J, Closa D, et al
    Involvement of extracellular vesicles in the macrophage-tumor cell communication in head and neck squamous cell carcinoma.
    PLoS One. 2019;14:e0224710.
    PubMed     Abstract available


  174. ABECASSIS J, Hamy AS, Laurent C, Sadacca B, et al
    Assessing reliability of intra-tumor heterogeneity estimates from single sample whole exome sequencing data.
    PLoS One. 2019;14:e0224143.
    PubMed     Abstract available


  175. KOCH C, Reitz C, Schreckenbach T, Eichler K, et al
    Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma.
    PLoS One. 2019;14:e0223613.
    PubMed     Abstract available


  176. GALVAO DE PODESTA OP, Peres SV, Salaroli LB, Cattafesta M, et al
    Consumption of minimally processed foods as protective factors in the genesis of squamous cell carcinoma of the head and neck in Brazil.
    PLoS One. 2019;14:e0220067.
    PubMed     Abstract available


  177. BECK ACC, Kieffer JM, Retel VP, van Overveld LFJ, et al
    Mapping the EORTC QLQ-C30 and QLQ-H&N35 to the EQ-5D for head and neck cancer: Can disease-specific utilities be obtained?
    PLoS One. 2019;14:e0226077.
    PubMed     Abstract available


  178. WOLOSZYNEK S, Mell JC, Zhao Z, Simpson G, et al
    Exploring thematic structure and predicted functionality of 16S rRNA amplicon data.
    PLoS One. 2019;14:e0219235.
    PubMed     Abstract available


  179. PIAZZESE C, Foley K, Whybra P, Hurt C, et al
    Discovery of stable and prognostic CT-based radiomic features independent of contrast administration and dimensionality in oesophageal cancer.
    PLoS One. 2019;14:e0225550.
    PubMed     Abstract available


  180. HUANG CI, Wang CC, Tai TS, Hwang TZ, et al
    eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy.
    PLoS One. 2019;14:e0225537.
    PubMed     Abstract available


  181. SUNNY S, Baby A, James BL, Balaji D, et al
    A smart tele-cytology point-of-care platform for oral cancer screening.
    PLoS One. 2019;14:e0224885.
    PubMed     Abstract available


  182. SANDBLOM V, Spetz J, Shubbar E, Montelius M, et al
    Gemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid cancer.
    PLoS One. 2019;14:e0225260.
    PubMed     Abstract available


  183. GUERLAIN J, Perie S, Lefevre M, Perez J, et al
    Localization and characterization of thyroid microcalcifications: A histopathological study.
    PLoS One. 2019;14:e0224138.
    PubMed     Abstract available


  184. CHEN PH, Chuang LY, Wu KC, Wang YH, et al
    Application of simulation-based CYP26 SNP-environment barcodes for evaluating the occurrence of oral malignant disorders by odds ratio-based binary particle swarm optimization: A case-control study in the Taiwanese population.
    PLoS One. 2019;14:e0220719.
    PubMed     Abstract available


  185. CHEN WY, Chen TC, Lai SF, Liang TH, et al
    Outcome of bimodality definitive chemoradiation does not differ from that of trimodality upfront neck dissection followed by adjuvant treatment for >6 cm lymph node (N3) head and neck cancer.
    PLoS One. 2019;14:e0225962.
    PubMed     Abstract available


  186. ABRAHAM M, Kordatou Z, Barriuso J, Lamarca A, et al
    Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer.
    PLoS One. 2019;14:e0224540.
    PubMed     Abstract available


  187. FONG PY, Tan SH, Lim DWT, Tan EH, et al
    Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).
    PLoS One. 2019;14:e0224665.
    PubMed     Abstract available


  188. YAN Z, Zhang J, Long H, Sun X, et al
    Correlation of CT texture changes with treatment response during radiation therapy for esophageal cancer: An exploratory study.
    PLoS One. 2019;14:e0223140.
    PubMed     Abstract available


  189. KELLY A, Barres B, Kwiatkowski F, Batisse-Lignier M, et al
    Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
    PLoS One. 2019;14:e0221298.
    PubMed     Abstract available


  190. KRAG AE, Kiil BJ, Hvas CL, Hvas AM, et al
    Effect of remote ischemic preconditioning on hemostasis and fibrinolysis in head and neck cancer surgery: A randomized controlled trial.
    PLoS One. 2019;14:e0219496.
    PubMed     Abstract available


    January 2018
  191. LUBINSKI J, Marciniak W, Muszynska M, Jaworowska E, et al
    Serum selenium levels and the risk of progression of laryngeal cancer.
    PLoS One. 2018;13:e0184873.
    PubMed     Abstract available


  192. KIM EK, Moon S, Kim DK, Zhang X, et al
    CXCL1 induces senescence of cancer-associated fibroblasts via autocrine loops in oral squamous cell carcinoma.
    PLoS One. 2018;13:e0188847.
    PubMed     Abstract available


  193. MONICO J, Miller B, Rezeanu L, May W, et al
    Fibroblast growth factor receptor 1 amplification in laryngeal squamous cell carcinoma.
    PLoS One. 2018;13:e0186185.
    PubMed     Abstract available


  194. PETRICK JL, Falk RT, Hyland PL, Caron P, et al
    Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study.
    PLoS One. 2018;13:e0190325.
    PubMed     Abstract available


  195. MARCUSSEN M, Sonderkaer M, Bodker JS, Andersen M, et al
    Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma.
    PLoS One. 2018;13:e0190709.
    PubMed     Abstract available


  196. TOPCAGIC J, Feldman R, Ghazalpour A, Swensen J, et al
    Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.
    PLoS One. 2018;13:e0191244.
    PubMed     Abstract available


  197. LI Z, Shan F, Wang Y, Zhang Y, et al
    Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis.
    PLoS One. 2018;13:e0189294.
    PubMed     Abstract available


  198. WU H, Zhang B, Li J, Liu Q, et al
    Echogenic foci with comet-tail artifact in resected thyroid nodules: Not an absolute predictor of benign disease.
    PLoS One. 2018;13:e0191505.
    PubMed     Abstract available


  199. AHMAD M, Suhaimi SN, Chu TL, Abdul Aziz N, et al
    Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma.
    PLoS One. 2018;13:e0191295.
    PubMed     Abstract available


  200. CHAUHAN AS, Prinja S, Ghoshal S, Verma R, et al
    Cost of treatment for head and neck cancer in India.
    PLoS One. 2018;13:e0191132.
    PubMed     Abstract available


  201. CHUERDUANGPHUI J, Ekalaksananan T, Chaiyarit P, Patarapadungkit N, et al
    Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M.
    PLoS One. 2018;13:e0192009.
    PubMed     Abstract available


  202. CHEA C, Miyauchi M, Inubushi T, Febriyanti Ayuningtyas N, et al
    Molecular mechanism of inhibitory effects of bovine lactoferrin on the growth of oral squamous cell carcinoma.
    PLoS One. 2018;13:e0191683.
    PubMed     Abstract available


  203. PERDOMO S, Anantharaman D, Foll M, Abedi-Ardekani B, et al
    Genomic analysis of head and neck cancer cases from two high incidence regions.
    PLoS One. 2018;13:e0191701.
    PubMed     Abstract available


  204. ANAYANNIS NV, Schlecht NF, Ben-Dayan M, Smith RV, et al
    Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma.
    PLoS One. 2018;13:e0191581.
    PubMed     Abstract available


  205. OHATA Y, Tsuchiya M, Hirai H, Yamaguchi S, et al
    Leukemia inhibitory factor produced by fibroblasts within tumor stroma participates in invasion of oral squamous cell carcinoma.
    PLoS One. 2018;13:e0191865.
    PubMed     Abstract available


  206. BOSCOLO-RIZZO P, Zorzi M, Del Mistro A, Da Mosto MC, et al
    The evolution of the epidemiological landscape of head and neck cancer in Italy: Is there evidence for an increase in the incidence of potentially HPV-related carcinomas?
    PLoS One. 2018;13:e0192621.
    PubMed     Abstract available


  207. VAN DEN BOORN HG, Engelhardt EG, van Kleef J, Sprangers MAG, et al
    Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0192310.
    PubMed     Abstract available


  208. SAILER V, Charpentier A, Dietrich J, Vogt TJ, et al
    Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas.
    PLoS One. 2018;13:e0192742.
    PubMed     Abstract available


  209. RIGALLI JP, Reichel M, Reuter T, Tocchetti GN, et al
    The pregnane X receptor (PXR) and the nuclear receptor corepressor 2 (NCoR2) modulate cell growth in head and neck squamous cell carcinoma.
    PLoS One. 2018;13:e0193242.
    PubMed     Abstract available


  210. MASUIKE Y, Tanaka K, Makino T, Yamasaki M, et al
    Esophageal squamous cell carcinoma with low mitochondrial copy number has mesenchymal and stem-like characteristics, and contributes to poor prognosis.
    PLoS One. 2018;13:e0193159.
    PubMed     Abstract available


  211. TICHY A, Kabacik S, O'Brien G, Pejchal J, et al
    The first in vivo multiparametric comparison of different radiation exposure biomarkers in human blood.
    PLoS One. 2018;13:e0193412.
    PubMed     Abstract available


  212. SANTOS JD, Meira KC, Simoes TC, Guimaraes RM, et al
    Inequalities in esophageal cancer mortality in Brazil: Temporal trends and projections.
    PLoS One. 2018;13:e0193135.
    PubMed     Abstract available


  213. NGUYEN VT, Dawson P, Zhang Q, Harris Z, et al
    Administration of growth factors promotes salisphere formation from irradiated parotid salivary glands.
    PLoS One. 2018;13:e0193942.
    PubMed     Abstract available


  214. SEO JW, Han K, Lee J, Kim EK, et al
    Application of metabolomics in prediction of lymph node metastasis in papillary thyroid carcinoma.
    PLoS One. 2018;13:e0193883.
    PubMed     Abstract available


  215. CUI J, Yan W, Xu S, Wang Q, et al
    Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.
    PLoS One. 2018;13:e0193171.
    PubMed     Abstract available


  216. TABERNA M, Mena M, Tous S, Pavon MA, et al
    HPV-relatedness definitions for classifying HPV-related oropharyngeal cancer patient do impact on TNM classification and patients' survival.
    PLoS One. 2018;13:e0194107.
    PubMed     Abstract available


  217. THIERAUF J, Weissinger SE, Veit JA, Affolter A, et al
    Low SOX2 expression marks a distinct subset of adenoid cystic carcinoma of the head and neck and is associated with an advanced tumor stage.
    PLoS One. 2018;13:e0194989.
    PubMed     Abstract available


  218. YEH CC, Su FH, Tzeng CR, Muo CH, et al
    Women with adenomyosis are at higher risks of endometrial and thyroid cancers: A population-based historical cohort study.
    PLoS One. 2018;13:e0194011.
    PubMed     Abstract available


  219. JUNG YS, Oh CM, Kim Y, Jung KW, et al
    Long-term survival of patients with thyroid cancer according to the methods of tumor detection: A nationwide cohort study in Korea.
    PLoS One. 2018;13:e0194743.
    PubMed     Abstract available


  220. ANANDAVADIVELAN P, Wikman A, Johar A, Lagergren P, et al
    Profiles of patient and tumour characteristics in relation to health-related quality of life after oesophageal cancer surgery.
    PLoS One. 2018;13:e0196187.
    PubMed     Abstract available


  221. HOVING AM, Kraeima J, Schepers RH, Dijkstra H, et al
    Optimisation of three-dimensional lower jaw resection margin planning using a novel Black Bone magnetic resonance imaging protocol.
    PLoS One. 2018;13:e0196059.
    PubMed     Abstract available


  222. SARKAR S, Alam N, Mandal SS, Chatterjee K, et al
    Differential transmission of the molecular signature of RBSP3, LIMD1 and CDC25A in basal/ parabasal versus spinous of normal epithelium during head and neck tumorigenesis: A mechanistic study.
    PLoS One. 2018;13:e0195937.
    PubMed     Abstract available


  223. SHIMIZU S, Miyazaki A, Sonoda T, Koike K, et al
    Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: With special reference to the mode of invasion and worst pattern of invasion.
    PLoS One. 2018;13:e0195451.
    PubMed     Abstract available


  224. PARK B, Min C, Choi HG
    Neck dissection does not increases the risk of stroke in thyroid cancer: A national cohort study.
    PLoS One. 2018;13:e0195074.
    PubMed     Abstract available


  225. MAIA LL, Peterle GT, Dos Santos M, Trivilin LO, et al
    JMJD1A, H3K9me1, H3K9me2 and ADM expression as prognostic markers in oral and oropharyngeal squamous cell carcinoma.
    PLoS One. 2018;13:e0194884.
    PubMed     Abstract available


  226. LOWE NM, Kershaw LE, Bernstein JM, Withey SB, et al
    Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapy.
    PLoS One. 2018;13:e0194841.
    PubMed     Abstract available


  227. PENG H, Chen L, Chen YP, Li WF, et al
    The current status of clinical trials focusing on nasopharyngeal carcinoma: A comprehensive analysis of ClinicalTrials.gov database.
    PLoS One. 2018;13:e0196730.
    PubMed     Abstract available


  228. TEICHMAN J, Dodbiba L, Thai H, Fleet A, et al
    Hedgehog inhibition mediates radiation sensitivity in mouse xenograft models of human esophageal adenocarcinoma.
    PLoS One. 2018;13:e0194809.
    PubMed     Abstract available


  229. TOVAR C, Patchett AL, Kim V, Wilson R, et al
    Heat shock proteins expressed in the marsupial Tasmanian devil are potential antigenic candidates in a vaccine against devil facial tumour disease.
    PLoS One. 2018;13:e0196469.
    PubMed     Abstract available


  230. CAUGHRON B, Yang Y, Young MRI
    Role of IL-23 signaling in the progression of premalignant oral lesions to cancer.
    PLoS One. 2018;13:e0196034.
    PubMed     Abstract available


  231. LIU F, Jin T, Liu L, Xiang Z, et al
    The role of concurrent chemotherapy for stage II nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0194733.
    PubMed     Abstract available


  232. GONG Y, Yang J, Wu W, Liu F, et al
    Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
    PLoS One. 2018;13:e0197007.
    PubMed     Abstract available


  233. GAGO-ARIAS A, Sanchez-Nieto B, Espinoza I, Karger CP, et al
    Impact of different biologically-adapted radiotherapy strategies on tumor control evaluated with a tumor response model.
    PLoS One. 2018;13:e0196310.
    PubMed     Abstract available


  234. BAN EZ, Lye MS, Chong PP, Yap YY, et al
    Association of hOGG1 Ser326Cys, ITGA2 C807T, TNF-A -308G>A and XPD Lys751Gln polymorphisms with the survival of Malaysian NPC patients.
    PLoS One. 2018;13:e0198332.
    PubMed     Abstract available


  235. ADAMS O, Janser FA, Dislich B, Berezowska S, et al
    A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.
    PLoS One. 2018;13:e0197610.
    PubMed     Abstract available


  236. KUBOTA A, Nakatani E, Tsukahara K, Hasegawa Y, et al
    Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
    PLoS One. 2018;13:e0198391.
    PubMed     Abstract available


  237. NAYAK S, Bhatt MLB, Goel MM, Gupta S, et al
    Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy.
    PLoS One. 2018;13:e0199665.
    PubMed     Abstract available


  238. GALDIERO MR, Varricchi G, Loffredo S, Bellevicine C, et al
    Potential involvement of neutrophils in human thyroid cancer.
    PLoS One. 2018;13:e0199740.
    PubMed     Abstract available


  239. URSU RG, Danciu M, Spiridon IA, Ridder R, et al
    Role of mucosal high-risk human papillomavirus types in head and neck cancers in Romania.
    PLoS One. 2018;13:e0199663.
    PubMed     Abstract available


  240. WANG Q, Guo Y, Zhang J, Shi L, et al
    Utility of high b-value (2000 sec/mm2) DWI with RESOLVE in differentiating papillary thyroid carcinomas and papillary thyroid microcarcinomas from benign thyroid nodules.
    PLoS One. 2018;13:e0200270.
    PubMed     Abstract available


  241. LABARGE B, Walter V, Lengerich EJ, Crist H, et al
    Evidence of a positive association between malpractice climate and thyroid cancer incidence in the United States.
    PLoS One. 2018;13:e0199862.
    PubMed     Abstract available


  242. LEE CY, Wu CF, Chen CM, Chang YY, et al
    Qualitative study for betel quid cessation among oral cancer patients.
    PLoS One. 2018;13:e0199503.
    PubMed     Abstract available


  243. WANG X, Huang S, Li X, Jiang D, et al
    A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma.
    PLoS One. 2018;13:e0200290.
    PubMed     Abstract available


  244. SUMI M, Nakamura T
    Salivary gland carcinoma: Prediction of cancer death risk based on apparent diffusion coefficient histogram profiles.
    PLoS One. 2018;13:e0200291.
    PubMed     Abstract available


  245. NAKAMURA R, Ishii H, Endo K, Hotta A, et al
    Reciprocal expression of Slug and Snail in human oral cancer cells.
    PLoS One. 2018;13:e0199442.
    PubMed     Abstract available


  246. SHI Y, Su C, Hu H, Yan H, et al
    Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma.
    PLoS One. 2018;13:e0198896.
    PubMed     Abstract available


  247. DOI Y, Murakami Y, Imano N, Takeuchi Y, et al
    Quantifying esophageal motion during free-breathing and breath-hold using fiducial markers in patients with early-stage esophageal cancer.
    PLoS One. 2018;13:e0198844.
    PubMed     Abstract available


  248. CHEN YH, Lu HI, Lo CM, Wang YM, et al
    The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
    PLoS One. 2018;13:e0198800.
    PubMed     Abstract available


  249. GADBAIL AR, Chaudhary M, Sarode SC, Gondivkar S, et al
    Ki67, CD105, and alpha-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis.
    PLoS One. 2018;13:e0200171.
    PubMed     Abstract available


  250. PISAMAI S, Roytrakul S, Phaonakrop N, Jaresitthikunchai J, et al
    Proteomic analysis of canine oral tumor tissues using MALDI-TOF mass spectrometry and in-gel digestion coupled with mass spectrometry (GeLC MS/MS) approaches.
    PLoS One. 2018;13:e0200619.
    PubMed     Abstract available


  251. KIM YR, Lee B, Byun MR, Lee JK, et al
    Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer.
    PLoS One. 2018;13:e0200509.
    PubMed     Abstract available


  252. LIN Z, Yang Z, He B, Wang D, et al
    Pattern of radiation-induced thyroid gland changes in nasopharyngeal carcinoma patients in 48 months after radiotherapy.
    PLoS One. 2018;13:e0200310.
    PubMed     Abstract available


  253. GUPTA T, Kannan S, Ghosh-Laskar S, Agarwal JP, et al
    Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma.
    PLoS One. 2018;13:e0200137.
    PubMed     Abstract available


  254. LI W, Zheng H, Xu J, Cao S, et al
    Imaging c-Met expression using 18F-labeled binding peptide in human cancer xenografts.
    PLoS One. 2018;13:e0199024.
    PubMed     Abstract available


  255. YANG SH, Lee TY, Ho CA, Yang CY, et al
    Exposure to nicotine-derived nitrosamine ketone and arecoline synergistically facilitates tumor aggressiveness via overexpression of epidermal growth factor receptor and its downstream signaling in head and neck squamous cell carcinoma.
    PLoS One. 2018;13:e0201267.
    PubMed     Abstract available


  256. SHIMAMURA M, Shibusawa N, Kurashige T, Mussazhanova Z, et al
    Mouse models of sporadic thyroid cancer derived from BRAFV600E alone or in combination with PTEN haploinsufficiency under physiologic TSH levels.
    PLoS One. 2018;13:e0201365.
    PubMed     Abstract available


  257. SEONG CY, Chai YJ, Lee SM, Kim SJ, et al
    Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.
    PLoS One. 2018;13:e0200166.
    PubMed     Abstract available


  258. LIN YS, Yeh CC, Huang SF, Chou YS, et al
    Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis.
    PLoS One. 2018;13:e0199014.
    PubMed     Abstract available


  259. NICOLAU UR, de Jesus VHF, Lima ENP, Alves MS, et al
    Early metabolic 18F-FDG PET/CT response of locally advanced squamous-cell carcinoma of head and neck to induction chemotherapy: A prospective pilot study.
    PLoS One. 2018;13:e0200823.
    PubMed     Abstract available


  260. DE SILVA RK, Siriwardena BSMS, Samaranayaka A, Abeyasinghe WAMUL, et al
    A model to predict nodal metastasis in patients with oral squamous cell carcinoma.
    PLoS One. 2018;13:e0201755.
    PubMed     Abstract available


  261. GE W, Jiao Y, Chang L
    The association between MTHFR gene polymorphisms (C677T, A1298C) and oral squamous cell carcinoma: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0202959.
    PubMed     Abstract available


  262. OWUSU-AFRIYIE O, Owiredu WKBA, Owusu-Danquah K, Larsen-Reindorf R, et al
    Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.
    PLoS One. 2018;13:e0202790.
    PubMed     Abstract available


  263. FAISAL M, Abu Bakar M, Sarwar A, Adeel M, et al
    Depth of invasion (DOI) as a predictor of cervical nodal metastasis and local recurrence in early stage squamous cell carcinoma of oral tongue (ESSCOT).
    PLoS One. 2018;13:e0202632.
    PubMed     Abstract available


  264. BASTOS DB, Sarafim-Silva BAM, Sundefeld MLMM, Ribeiro AA, et al
    Circulating catecholamines are associated with biobehavioral factors and anxiety symptoms in head and neck cancer patients.
    PLoS One. 2018;13:e0202515.
    PubMed     Abstract available


  265. LEE CH, Jung JH, Son SH, Hong CM, et al
    Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer.
    PLoS One. 2018;13:e0202644.
    PubMed     Abstract available


  266. HUBERT JN, Zerjal T, Hospital F
    Cancer- and behavior-related genes are targeted by selection in the Tasmanian devil (Sarcophilus harrisii).
    PLoS One. 2018;13:e0201838.
    PubMed     Abstract available


  267. SHI L, Lai Y, Chen S, Fu L, et al
    Dosimetric superiority of IMRT with jaw tracking technique for whole esophagus and T-shaped field radiotherapy in advanced esophageal cancer.
    PLoS One. 2018;13:e0202628.
    PubMed     Abstract available


  268. BASHIR K, Sarwar R, Saeed S, Mahjabeen I, et al
    Interaction among susceptibility genotypes of PARP1 SNPs in thyroid carcinoma.
    PLoS One. 2018;13:e0199007.
    PubMed     Abstract available


  269. LECONTE BA, Szaniszlo P, Fennewald SM, Lou DI, et al
    Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer.
    PLoS One. 2018;13:e0203403.
    PubMed     Abstract available


  270. ZHAO X, Ren Y, Hu Y, Cui N, et al
    Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or the gastroesophageal junction: A meta-analysis based on clinical trials.
    PLoS One. 2018;13:e0202185.
    PubMed     Abstract available


  271. KIM DS, Kim DW, Heo YJ, Baek JW, et al
    Utility of including BRAF mutation analysis with ultrasonographic and cytological diagnoses in ultrasonography-guided fine-needle aspiration of thyroid nodules.
    PLoS One. 2018;13:e0202687.
    PubMed     Abstract available


  272. REZAPOUR A, Jahangiri R, Olyaeemanesh A, Kalaghchi B, et al
    The economic burden of oral cancer in Iran.
    PLoS One. 2018;13:e0203059.
    PubMed     Abstract available


  273. LOHSE I, Al-Ali H, Volmar CH, D Alvarez Trotta A, et al
    Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma.
    PLoS One. 2018;13:e0203173.
    PubMed     Abstract available


  274. PARK YM, Go YY, Shin SH, Cho JG, et al
    Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death.
    PLoS One. 2018;13:e0203069.
    PubMed     Abstract available


  275. CHO JK, Lee GJ, Kim HD, Moon UY, et al
    Differential impact of circulating tumor cells on disease recurrence and survivals in patients with head and neck squamous cell carcinomas: An updated meta-analysis.
    PLoS One. 2018;13:e0203758.
    PubMed     Abstract available


  276. MEYER HJ, Purz S, Sabri O, Surov A, et al
    Relationships between histogram analysis of ADC values and complex 18F-FDG-PET parameters in head and neck squamous cell carcinoma.
    PLoS One. 2018;13:e0202897.
    PubMed     Abstract available


  277. MA W, Concha-Benavente F, Santegoets SJAM, Welters MJP, et al
    EGFR signaling suppresses type 1 cytokine-induced T-cell attracting chemokine secretion in head and neck cancer.
    PLoS One. 2018;13:e0203402.
    PubMed     Abstract available


  278. CHEN JL, Chang CC, Huang YS, Kuo HY, et al
    Persistently elevated soluble MHC class I polypeptide-related sequence A and transforming growth factor-beta1 levels are poor prognostic factors in head and neck squamous cell carcinoma after definitive chemoradiotherapy.
    PLoS One. 2018;13:e0202224.
    PubMed     Abstract available


  279. FAN HC, Chen CY, Hsu YC, Chou RH, et al
    Increased risk of incident nasopharyngeal carcinoma with exposure to air pollution.
    PLoS One. 2018;13:e0204568.
    PubMed     Abstract available


  280. FACCIN TC, Cargnelutti JF, Rodrigues FS, Menezes FR, et al
    Bovine upper alimentary squamous cell carcinoma associated with bracken fern poisoning: Clinical-pathological aspects and etiopathogenesis of 100 cases.
    PLoS One. 2018;13:e0204656.
    PubMed     Abstract available


  281. LOHAVANICHBUTR P, Zhang Y, Wang P, Gu H, et al
    Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls.
    PLoS One. 2018;13:e0204249.
    PubMed     Abstract available


  282. KYRIAKIDOU G, Friedrich-Rust M, Bon D, Sircar I, et al
    Comparison of strain elastography, point shear wave elastography using acoustic radiation force impulse imaging and 2D-shear wave elastography for the differentiation of thyroid nodules.
    PLoS One. 2018;13:e0204095.
    PubMed     Abstract available


  283. GASIOR-PERCZAK D, Palyga I, Szymonek M, Kowalik A, et al
    The impact of BMI on clinical progress, response to treatment, and disease course in patients with differentiated thyroid cancer.
    PLoS One. 2018;13:e0204668.
    PubMed     Abstract available


  284. HUNG YH, Liu SA, Wang CC, Wang CP, et al
    Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck.
    PLoS One. 2018;13:e0205365.
    PubMed     Abstract available


  285. ABRAMOWITZ L, Lacau Saint Guily J, Moyal-Barracco M, Bergeron C, et al
    Epidemiological and economic burden of potentially HPV-related cancers in France.
    PLoS One. 2018;13:e0202564.
    PubMed     Abstract available


  286. ZAMMIT AP, Sinha R, Cooper CL, Perry CFL, et al
    Examining the contribution of smoking and HPV towards the etiology of oral cavity squamous cell carcinoma using high-throughput sequencing: A prospective observational study.
    PLoS One. 2018;13:e0205406.
    PubMed     Abstract available


  287. HOUSE R, Majumder M, Janakiraman H, Ogretmen B, et al
    Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer.
    PLoS One. 2018;13:e0205077.
    PubMed     Abstract available


  288. CHOI CH, Park SY, Park JM, Wu HG, et al
    Comparison of the IPSA and HIPO algorithms for interstitial tongue high-dose-rate brachytherapy.
    PLoS One. 2018;13:e0205229.
    PubMed     Abstract available


  289. BANO N, Yadav M, Mohania D, Das BC, et al
    The role of NF-kappaB and miRNA in oral cancer and cancer stem cells with or without HPV16 infection.
    PLoS One. 2018;13:e0205518.
    PubMed     Abstract available


  290. BAUMEISTER P, Canis M, Reiter M
    Preoperative anemia and perioperative blood transfusion in head and neck squamous cell carcinoma.
    PLoS One. 2018;13:e0205712.
    PubMed     Abstract available


  291. TASNEEM S, Sarwar MT, Bashir MR, Hussain H, et al
    Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma.
    PLoS One. 2018;13:e0205508.
    PubMed     Abstract available


  292. WANG F, Wang JD, Hung YW
    Universal health insurance, health inequality and oral cancer in Taiwan.
    PLoS One. 2018;13:e0205731.
    PubMed     Abstract available


  293. JACKOWSKA J, Klimza H, Winiarski P, Piersiala K, et al
    The usefulness of narrow band imaging in the assessment of laryngeal papillomatosis.
    PLoS One. 2018;13:e0205554.
    PubMed     Abstract available


  294. VOSSEN DM, Verhagen CVM, Grenman R, Kluin RJC, et al
    Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint association.
    PLoS One. 2018;13:e0206632.
    PubMed     Abstract available


  295. LEE JS, Mun JH
    Dermoscopy of venous lake on the lips: A comparative study with labial melanotic macule.
    PLoS One. 2018;13:e0206768.
    PubMed     Abstract available


  296. TOPTAN T, Brusadelli MG, Turpin B, Witte DP, et al
    Limited detection of human polyomaviruses in Fanconi anemia related squamous cell carcinoma.
    PLoS One. 2018;13:e0209235.
    PubMed     Abstract available


    January 2017
  297. LINEDALE R, Schmidt C, King BT, Ganko AG, et al
    Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients.
    PLoS One. 2017;12:e0175755.
    PubMed     Abstract available


  298. LI X, Zhang Y, Shi Y, Wu S, et al
    Comprehensive evaluation of ten deformable image registration algorithms for contour propagation between CT and cone-beam CT images in adaptive head & neck radiotherapy.
    PLoS One. 2017;12:e0175906.
    PubMed     Abstract available


  299. CAMPO C, Kohler A, Figlioli G, Elisei R, et al
    Inherited variants in genes somatically mutated in thyroid cancer.
    PLoS One. 2017;12:e0174995.
    PubMed     Abstract available


  300. TADAKAMADLA J, Kumar S, Lalloo R, Johnson NW, et al
    Qualitative analysis of the impact of Oral Potentially Malignant Disorders on daily life activities.
    PLoS One. 2017;12:e0175531.
    PubMed     Abstract available


  301. WANG F, Ding X, Wang T, Shan Z, et al
    Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin.
    PLoS One. 2017;12:e0174276.
    PubMed     Abstract available


  302. KIM SY, Lee E, Nam SJ, Kim EK, et al
    Ultrasound texture analysis: Association with lymph node metastasis of papillary thyroid microcarcinoma.
    PLoS One. 2017;12:e0176103.
    PubMed     Abstract available


  303. LIU SL, Lin HX, Qiu F, Zhang WJ, et al
    Overexpression of Kinesin Family Member 20A Correlates with Disease Progression and Poor Prognosis in Human Nasopharyngeal Cancer: A Retrospective Analysis of 105 Patients.
    PLoS One. 2017;12:e0169280.
    PubMed     Abstract available


  304. CATALANI S, Palma F, Battistelli S, Benedetti S, et al
    Oxidative stress and apoptosis induction in human thyroid carcinoma cells exposed to the essential oil from Pistacia lentiscus aerial parts.
    PLoS One. 2017;12:e0172138.
    PubMed     Abstract available


  305. LIU M, Wang SJ, Yang X, Peng H, et al
    Diagnostic Efficacy of Sentinel Lymph Node Biopsy in Early Oral Squamous Cell Carcinoma: A Meta-Analysis of 66 Studies.
    PLoS One. 2017;12:e0170322.
    PubMed     Abstract available


  306. HU Q, Sun TT, Hong J, Fang JY, et al
    Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett's Esophagus: A Systematic Review and Meta-Analysis.
    PLoS One. 2017;12:e0169691.
    PubMed     Abstract available


  307. HUA Z, Zheng X, Xue H, Wang J, et al
    Long-term trends and survival analysis of esophageal and gastric cancer in Yangzhong, 1991-2013.
    PLoS One. 2017;12:e0173896.
    PubMed     Abstract available


  308. CAI F, Xiao X, Niu X, Zhong Y, et al
    Association between promoter methylation of DAPK gene and HNSCC: A meta-analysis.
    PLoS One. 2017;12:e0173194.
    PubMed     Abstract available


  309. DMELLO C, Sawant S, Alam H, Gangadaran P, et al
    Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients.
    PLoS One. 2017;12:e0172559.
    PubMed     Abstract available


  310. CHAN DL, Sjoquist KM, Goldstein D, Price TJ, et al
    The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0172307.
    PubMed     Abstract available


  311. PAN H, Gu L, Liu B, Li Y, et al
    Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma.
    PLoS One. 2017;12:e0168900.
    PubMed     Abstract available


  312. HUNG SY, Loh CY, Kwon SH, Tsai CH, et al
    Assessing the suitability of medial sural artery perforator flaps in tongue reconstruction - An outcome study.
    PLoS One. 2017;12:e0171570.
    PubMed     Abstract available


  313. SHAH AT, Heaster TM, Skala MC
    Metabolic Imaging of Head and Neck Cancer Organoids.
    PLoS One. 2017;12:e0170415.
    PubMed     Abstract available


  314. KIM Y, Kim MH, Jeon S, Kim J, et al
    Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma.
    PLoS One. 2017;12:e0174737.
    PubMed     Abstract available


  315. SOLARTE VA, Conget P, Vernot JP, Rosas JE, et al
    A tetrameric peptide derived from bovine lactoferricin as a potential therapeutic tool for oral squamous cell carcinoma: A preclinical model.
    PLoS One. 2017;12:e0174707.
    PubMed     Abstract available


  316. XIAO Y, Ouyang C, Huang W, Tang Y, et al
    Annexin A1 can inhibit the in vitro invasive ability of nasopharyngeal carcinoma cells possibly through Annexin A1/S100A9/Vimentin interaction.
    PLoS One. 2017;12:e0174383.
    PubMed     Abstract available


  317. TSAI HT, Hsieh MJ, Lin CW, Su SC, et al
    Combinations of SERPINB5 gene polymorphisms and environmental factors are associated with oral cancer risks.
    PLoS One. 2017;12:e0163369.
    PubMed     Abstract available


  318. ZHANG W, Yu D, Peng J, Xu J, et al
    Gastric-tube versus whole-stomach esophagectomy for esophageal cancer: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0173416.
    PubMed     Abstract available


  319. SUN X, Zhao D, Liu Y, Liu Y, et al
    The long-term spatial-temporal trends and burden of esophageal cancer in one high-risk area: A population-registered study in Feicheng, China.
    PLoS One. 2017;12:e0173211.
    PubMed     Abstract available


  320. SCHWARTZ DL, Sosa A, Chun SG, Ding C, et al
    SBRT for early-stage glottic larynx cancer-Initial clinical outcomes from a phase I clinical trial.
    PLoS One. 2017;12:e0172055.
    PubMed     Abstract available


  321. HERNANDEZ BY, Zhu X, Goodman MT, Gatewood R, et al
    Betel nut chewing, oral premalignant lesions, and the oral microbiome.
    PLoS One. 2017;12:e0172196.
    PubMed     Abstract available


  322. HASSAN MS, Awasthi N, Li J, Schwarz MA, et al
    A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinoma.
    PLoS One. 2017;12:e0171824.
    PubMed     Abstract available


  323. ZHOU J, Yang Y, Zhang D, Zhou L, et al
    Genetic polymorphisms and plasma levels of BCL11A contribute to the development of laryngeal squamous cell carcinoma.
    PLoS One. 2017;12:e0171116.
    PubMed     Abstract available


  324. BARASCH N, Gong X, Kwei KA, Varma S, et al
    Recurrent rearrangements of the Myb/SANT-like DNA-binding domain containing 3 gene (MSANTD3) in salivary gland acinic cell carcinoma.
    PLoS One. 2017;12:e0171265.
    PubMed     Abstract available


  325. CHOU CH, Chou YE, Chuang CY, Yang SF, et al
    Combined effect of genetic polymorphisms of AURKA and environmental factors on oral cancer development in Taiwan.
    PLoS One. 2017;12:e0171583.
    PubMed     Abstract available


  326. GAO XL, Wu JS, Cao MX, Gao SY, et al
    Cytokeratin-14 contributes to collective invasion of salivary adenoid cystic carcinoma.
    PLoS One. 2017;12:e0171341.
    PubMed     Abstract available


  327. SAKAKIBARA A, Sakakibara S, Kusumoto J, Takeda D, et al
    Upregulated Expression of Transient Receptor Potential Cation Channel Subfamily V Receptors in Mucosae of Patients with Oral Squamous Cell Carcinoma and Patients with a History of Alcohol Consumption or Smoking.
    PLoS One. 2017;12:e0169723.
    PubMed     Abstract available


  328. HUANG CI, Lin LC, Tien HC, Que J, et al
    Hyperlipidemia and statins use for the risk of new-onset anxiety/depression in patients with head and neck cancer: A population-based study.
    PLoS One. 2017;12:e0174574.
    PubMed     Abstract available


  329. LETSOLO BT, Jones RE, Rowson J, Grimstead JW, et al
    Extensive telomere erosion is consistent with localised clonal expansions in Barrett's metaplasia.
    PLoS One. 2017;12:e0174833.
    PubMed     Abstract available


  330. KOIRE A, Kim YW, Wang J, Katsonis P, et al
    Codon-level co-occurrences of germline variants and somatic mutations in cancer are rare but often lead to incorrect variant annotation and underestimated impact prediction.
    PLoS One. 2017;12:e0174766.
    PubMed     Abstract available


  331. DESBORDES P, Ruan S, Modzelewski R, Pineau P, et al
    Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier.
    PLoS One. 2017;12:e0173208.
    PubMed     Abstract available


  332. LIN JD, Lin SF, Chen ST, Hsueh C, et al
    Long-term follow-up of papillary and follicular thyroid carcinomas with bone metastasis.
    PLoS One. 2017;12:e0173354.
    PubMed     Abstract available


  333. CHEN CH, Lu HI, Wang YM, Chen YH, et al
    Areca nut is associated with younger age of diagnosis, poor chemoradiotherapy response, and shorter overall survival in esophageal squamous cell carcinoma.
    PLoS One. 2017;12:e0172752.
    PubMed     Abstract available


  334. LIN SF, Lin JD, Hsueh C, Chou TC, et al
    A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.
    PLoS One. 2017;12:e0172315.
    PubMed     Abstract available


  335. JIN YB, Zhang GY, Lin KR, Chen XP, et al
    Changes of plasma cytokines and chemokines expression level in nasopharyngeal carcinoma patients after treatment with definitive intensity-modulated radiotherapy (IMRT).
    PLoS One. 2017;12:e0172264.
    PubMed     Abstract available


  336. ZHANG M, Qin Y, Zuo B, Gong W, et al
    Overexpression of NOTCH-regulated Ankyrin Repeat Protein is associated with papillary thyroid carcinoma progression.
    PLoS One. 2017;12:e0167782.
    PubMed     Abstract available


  337. ALBANO PM, Holzinger D, Salvador C, Orosa J 3rd, et al
    Low prevalence of human papillomavirus in head and neck squamous cell carcinoma in the northwest region of the Philippines.
    PLoS One. 2017;12:e0172240.
    PubMed     Abstract available


  338. YANG Y, Jia J, Sun Z, Du F, et al
    Prognosis impact of clinical characteristics in patients with inoperable esophageal squamous cell carcinoma.
    PLoS One. 2017;12:e0182660.
    PubMed     Abstract available


  339. KATAYAMA I, Eida S, Fujita S, Hotokezaka Y, et al
    Perfusion MR imaging detection of carcinoma arising from preexisting salivary gland pleomorphic adenoma by computer-assisted analysis of time-signal intensity maps.
    PLoS One. 2017;12:e0178002.
    PubMed     Abstract available


  340. CHEN FP, Zhou GQ, Qi ZY, Lin L, et al
    Prognostic value of cervical nodal tumor volume in nasopharyngeal carcinoma: Analysis of 1230 patients with positive cervical nodal metastasis.
    PLoS One. 2017;12:e0176995.
    PubMed     Abstract available


  341. TRESS B, Dorn ES, Suchodolski JS, Nisar T, et al
    Bacterial microbiome of the nose of healthy dogs and dogs with nasal disease.
    PLoS One. 2017;12:e0176736.
    PubMed     Abstract available


  342. LEE BH, Neela PH, Kent MS, Zehnder AM, et al
    IQGAP1 is an oncogenic target in canine melanoma.
    PLoS One. 2017;12:e0176370.
    PubMed     Abstract available


  343. MONTENEGRO CF, Casali BC, Lino RLB, Pachane BC, et al
    Inhibition of alphavbeta3 integrin induces loss of cell directionality of oral squamous carcinoma cells (OSCC).
    PLoS One. 2017;12:e0176226.
    PubMed     Abstract available


  344. LAU HK, Wu ER, Chen MK, Hsieh MJ, et al
    Effect of genetic variation in microRNA binding site in WNT1-inducible signaling pathway protein 1 gene on oral squamous cell carcinoma susceptibility.
    PLoS One. 2017;12:e0176246.
    PubMed     Abstract available


  345. WANG JH, Zhang L, Huang ST, Xu J, et al
    Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma.
    PLoS One. 2017;12:e0175280.
    PubMed     Abstract available


  346. TSAI WC, Kung PT, Wang YH, Huang KH, et al
    Influence of time interval from diagnosis to treatment on survival for oral cavity cancer: A nationwide cohort study.
    PLoS One. 2017;12:e0175148.
    PubMed     Abstract available


  347. VINCENT-CHONG VK, Salahshourifar I, Woo KM, Anwar A, et al
    Genome wide profiling in oral squamous cell carcinoma identifies a four genetic marker signature of prognostic significance.
    PLoS One. 2017;12:e0174865.
    PubMed     Abstract available


  348. CHEN L, Yang J, Xing Z, Yuan F, et al
    An integrated method for the identification of novel genes related to oral cancer.
    PLoS One. 2017;12:e0175185.
    PubMed     Abstract available


  349. YOKOYAMA A, Katada C, Yokoyama T, Yano T, et al
    Alcohol abstinence and risk assessment for second esophageal cancer in Japanese men after mucosectomy for early esophageal cancer.
    PLoS One. 2017;12:e0175182.
    PubMed     Abstract available


  350. MA J, Ren Y, Zhang L, Kong X, et al
    Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    PLoS One. 2017;12:e0174309.
    PubMed     Abstract available


  351. LI N, Lu Y, Li D, Zheng X, et al
    All-trans retinoic acid suppresses the angiopoietin-Tie2 pathway and inhibits angiogenesis and metastasis in esophageal squamous cell carcinoma.
    PLoS One. 2017;12:e0174555.
    PubMed     Abstract available


  352. PISARSKA M, Malczak P, Major P, Wysocki M, et al
    Enhanced recovery after surgery protocol in oesophageal cancer surgery: Systematic review and meta-analysis.
    PLoS One. 2017;12:e0174382.
    PubMed     Abstract available


  353. FRANCESCHI S, Lessi F, Panebianco F, Tantillo E, et al
    Loss of c-KIT expression in thyroid cancer cells.
    PLoS One. 2017;12:e0173913.
    PubMed     Abstract available


  354. YANG G, Deng Q, Fan W, Zhang Z, et al
    Cyclooxygenase-2 expression is positively associated with lymph node metastasis in nasopharyngeal carcinoma.
    PLoS One. 2017;12:e0173641.
    PubMed     Abstract available


  355. EGASHIRA A, Morita M, Kumagai R, Taguchi KI, et al
    Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases.
    PLoS One. 2017;12:e0173501.
    PubMed     Abstract available


  356. PENG N, Shi L, Zhang Q, Hu Y, et al
    Microarray profiling of circular RNAs in human papillary thyroid carcinoma.
    PLoS One. 2017;12:e0170287.
    PubMed     Abstract available


  357. ZHANG Y, Ma L, Huang J, Shuang J, et al
    The effect of paclitaxel-eluting covered metal stents versus covered metal stents in a rabbit esophageal squamous carcinoma model.
    PLoS One. 2017;12:e0173262.
    PubMed     Abstract available


  358. WEN YF, Yang XZ, Zeng LS, Peng HH, et al
    Prognostic impact of pretherapeutic gamma-glutamyltransferase on patients with nasopharyngeal carcinoma.
    PLoS One. 2017;12:e0172345.
    PubMed     Abstract available


  359. ZHANG Y, Li Z, Zhang J, Li H, et al
    Genetic Variants in MTHFR Gene Predict >/= 2 Radiation Pneumonitis in Esophageal Squamous Cell Carcinoma Patients Treated with Thoracic Radiotherapy.
    PLoS One. 2017;12:e0169147.
    PubMed     Abstract available


  360. SAILER V, Gevensleben H, Dietrich J, Goltz D, et al
    Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma.
    PLoS One. 2017;12:e0179412.
    PubMed     Abstract available


  361. FANG CY, Wu CC, Fang CL, Chen WY, et al
    Long-term growth comparison studies of FBS and FBS alternatives in six head and neck cell lines.
    PLoS One. 2017;12:e0178960.
    PubMed     Abstract available


  362. HAYES DA, Kunde DA, Taylor RL, Pyecroft SB, et al
    ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1).
    PLoS One. 2017;12:e0177919.
    PubMed     Abstract available


  363. CSOSZ E, Labiscsak P, Kallo G, Markus B, et al
    Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.
    PLoS One. 2017;12:e0177282.
    PubMed     Abstract available


  364. BEYREUTHER E, Bruchner K, Krause M, Schmidt M, et al
    An optimized small animal tumour model for experimentation with low energy protons.
    PLoS One. 2017;12:e0177428.
    PubMed     Abstract available


  365. MOREIRA MA, Lessa LS, Bortoli FR, Lopes A, et al
    Meta-analysis of magnetic resonance imaging accuracy for diagnosis of oral cancer.
    PLoS One. 2017;12:e0177462.
    PubMed     Abstract available


  366. INGRAM WS, Yang J, Beadle BM, Wendt R 3rd, et al
    The feasibility of endoscopy-CT image registration in the head and neck without prospective endoscope tracking.
    PLoS One. 2017;12:e0177886.
    PubMed     Abstract available


  367. ZHAO XK, Mao YM, Meng H, Song X, et al
    Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China.
    PLoS One. 2017;12:e0177504.
    PubMed     Abstract available


  368. LI P, Bian XY, Chen Q, Yao XF, et al
    Blocking of stromal interaction molecule 1 expression influence cell proliferation and promote cell apoptosis in vitro and inhibit tumor growth in vivo in head and neck squamous cell carcinoma.
    PLoS One. 2017;12:e0177484.
    PubMed     Abstract available


  369. ZHANG P, Li XM, Zhao XK, Song X, et al
    Novel genetic locus at MHC region for esophageal squamous cell carcinoma in Chinese populations.
    PLoS One. 2017;12:e0177494.
    PubMed     Abstract available


  370. WANG C, Zhang X, Li H, Li X, et al
    Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis.
    PLoS One. 2017;12:e0179664.
    PubMed     Abstract available


  371. KRONBORG TM, Hansen JF, Rasmussen AK, Vorkamp K, et al
    The flame retardant DE-71 (a mixture of polybrominated diphenyl ethers) inhibits human differentiated thyroid cell function in vitro.
    PLoS One. 2017;12:e0179858.
    PubMed     Abstract available


  372. KOWALIK A, Kowalska A, Walczyk A, Chodurska R, et al
    Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.
    PLoS One. 2017;12:e0179691.
    PubMed     Abstract available


  373. MIN YW, Jang EY, Jung JH, Lee H, et al
    Comparison between gastrostomy feeding and self-expandable metal stent insertion for patients with esophageal cancer and dysphagia.
    PLoS One. 2017;12:e0179522.
    PubMed     Abstract available


  374. FLORIO R, De Lellis L, di Giacomo V, Di Marcantonio MC, et al
    Effects of PPARalpha inhibition in head and neck paraganglioma cells.
    PLoS One. 2017;12:e0178995.
    PubMed     Abstract available


  375. LEON ME, Assefa M, Kassa E, Bane A, et al
    Qat use and esophageal cancer in Ethiopia: A pilot case-control study.
    PLoS One. 2017;12:e0178911.
    PubMed     Abstract available


  376. GUU SY, Lin TH, Chang SC, Wang RJ, et al
    Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients.
    PLoS One. 2017;12:e0178927.
    PubMed     Abstract available


  377. BARATTO L, Park SY, Hatami N, Davidzon G, et al
    18F-FDG silicon photomultiplier PET/CT: A pilot study comparing semi-quantitative measurements with standard PET/CT.
    PLoS One. 2017;12:e0178936.
    PubMed     Abstract available


  378. PARK YM, Lee SM, Kim DW, Shin SC, et al
    Predictive factors of right paraesophageal lymph node metastasis in papillary thyroid carcinoma: Single center experience and meta-analysis.
    PLoS One. 2017;12:e0177956.
    PubMed     Abstract available


  379. OSAZUWA-PETERS N, Adjei Boakye E, Hussaini AS, Sujijantarat N, et al
    Characteristics and predictors of oral cancer knowledge in a predominantly African American community.
    PLoS One. 2017;12:e0177787.
    PubMed     Abstract available


  380. VAN DER HOORN A, van Laar PJ, Holtman GA, Westerlaan HE, et al
    Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with head and neck tumors, a systematic review and meta-analysis.
    PLoS One. 2017;12:e0177986.
    PubMed     Abstract available


  381. YAMASHITA H, Seto Y, Takenaka R, Okuma K, et al
    Survival comparison between radical surgery and definitive chemoradiation in 267 esophageal squamous cell carcinomas in a single institution: A propensity-matched study.
    PLoS One. 2017;12:e0177133.
    PubMed     Abstract available


  382. CHEN L, Liu X, Gao L, Wang R, et al
    The clinicopathological features and prognosis of signet ring cell carcinoma of the esophagus: A 10-year retrospective study in China.
    PLoS One. 2017;12:e0176637.
    PubMed     Abstract available


  383. LUBITZ C, Ali A, Zhan T, Heberle C, et al
    The thyroid cancer policy model: A mathematical simulation model of papillary thyroid carcinoma in The U.S. population.
    PLoS One. 2017;12:e0177068.
    PubMed     Abstract available


  384. CHOI YJ, Lee DH, Han KD, Yoon H, et al
    Elevated serum gamma-glutamyltransferase is associated with an increased risk of oesophageal carcinoma in a cohort of 8,388,256 Korean subjects.
    PLoS One. 2017;12:e0177053.
    PubMed     Abstract available


  385. ALVARADO D, Ligon GF, Lillquist JS, Seibel SB, et al
    ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.
    PLoS One. 2017;12:e0181356.
    PubMed     Abstract available


  386. HUANG ZG, Gao BX, Chen H, Yang MX, et al
    An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis.
    PLoS One. 2017;12:e0181069.
    PubMed     Abstract available


  387. BRANDSTORP-BOESEN J, Sorum Falk R, Boysen M, Brondbo K, et al
    Impact of stage, management and recurrence on survival rates in laryngeal cancer.
    PLoS One. 2017;12:e0179371.
    PubMed     Abstract available


  388. LIU PF, Hu YC, Kang BH, Tseng YK, et al
    Expression levels of cleaved caspase-3 and caspase-3 in tumorigenesis and prognosis of oral tongue squamous cell carcinoma.
    PLoS One. 2017;12:e0180620.
    PubMed     Abstract available


  389. LI H, Jiang C, Wu D, Shi S, et al
    The prognostic and clinicopathologic characteristics of CD147 and esophagus cancer: A meta-analysis.
    PLoS One. 2017;12:e0180271.
    PubMed     Abstract available


  390. KHAN Z, Dreger S, Shah SMH, Pohlabeln H, et al
    Oral cancer via the bargain bin: The risk of oral cancer associated with a smokeless tobacco product (Naswar).
    PLoS One. 2017;12:e0180445.
    PubMed     Abstract available


  391. MAGNES T, Melchardt T, Weiss L, Mittermair C, et al
    Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
    PLoS One. 2017;12:e0180995.
    PubMed     Abstract available


  392. HUANG YH, Yeh CH, Cheng NM, Lin CY, et al
    Cystic nodal metastasis in patients with oropharyngeal squamous cell carcinoma receiving chemoradiotherapy: Relationship with human papillomavirus status and failure patterns.
    PLoS One. 2017;12:e0180779.
    PubMed     Abstract available


  393. CHOW LQ, Santana-Davila R, Pantel A, Roth M, et al
    A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine.
    PLoS One. 2017;12:e0178325.
    PubMed     Abstract available


  394. JEGERLEHNER S, Bulliard JL, Aujesky D, Rodondi N, et al
    Overdiagnosis and overtreatment of thyroid cancer: A population-based temporal trend study.
    PLoS One. 2017;12:e0179387.
    PubMed     Abstract available


  395. LI J, Wang P, Xu Y
    Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0179536.
    PubMed     Abstract available


  396. LIU PF, Kang BH, Wu YM, Sun JH, et al
    Vimentin is a potential prognostic factor for tongue squamous cell carcinoma among five epithelial-mesenchymal transition-related proteins.
    PLoS One. 2017;12:e0178581.
    PubMed     Abstract available


  397. YANG D, Wang C, Luo Y, Li X, et al
    Activated E2F activity induces cell death in papillary thyroid carcinoma K1 cells with enhanced Wnt signaling.
    PLoS One. 2017;12:e0178908.
    PubMed     Abstract available


  398. KANG YY, Liu Y, Wang ML, Guo M, et al
    Construction and analyses of the microRNA-target gene differential regulatory network in thyroid carcinoma.
    PLoS One. 2017;12:e0178331.
    PubMed     Abstract available


  399. SOARES PO, Maluf Cury P, Mendoza Lopez RV, Cernea CR, et al
    GTSP1 expression in non-smoker and non-drinker patients with squamous cell carcinoma of the head and neck.
    PLoS One. 2017;12:e0182600.
    PubMed     Abstract available


  400. QIU WZ, Ke LR, Xia WX, Yang J, et al
    A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy.
    PLoS One. 2017;12:e0182963.
    PubMed     Abstract available


  401. DAVE E, Ozbek U, Gupta V, Genden E, et al
    The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer.
    PLoS One. 2017;12:e0181108.
    PubMed     Abstract available


  402. REYES-GIBBY CC, Melkonian SC, Wang J, Yu RK, et al
    Identifying novel genes and biological processes relevant to the development of cancer therapy-induced mucositis: An informative gene network analysis.
    PLoS One. 2017;12:e0180396.
    PubMed     Abstract available


  403. KOLB M, Kurz S, Schafer A, Huse K, et al
    Verification and characterization of an alternative low density lipoprotein receptor-related protein 1 splice variant.
    PLoS One. 2017;12:e0180354.
    PubMed     Abstract available


  404. VOJTECHOVA Z, Zavadil J, Klozar J, Grega M, et al
    Comparison of the miRNA expression profiles in fresh frozen and formalin-fixed paraffin-embedded tonsillar tumors.
    PLoS One. 2017;12:e0179645.
    PubMed     Abstract available


  405. ZHANG E, Xu Z, Duan W, Huang S, et al
    Association between polymorphisms in pre-miRNA genes and risk of oral squamous cell cancer in a Chinese population.
    PLoS One. 2017;12:e0176044.
    PubMed     Abstract available


  406. BUFFET C, Hecale-Perlemoine K, Bricaire L, Dumont F, et al
    DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
    PLoS One. 2017;12:e0184861.
    PubMed     Abstract available


  407. HUTAJULU SH, Fachiroh J, Argy G, Indrasari SR, et al
    Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area.
    PLoS One. 2017;12:e0180683.
    PubMed     Abstract available


  408. SIEMERS NO, Holloway JL, Chang H, Chasalow SD, et al
    Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors.
    PLoS One. 2017;12:e0179726.
    PubMed     Abstract available


  409. MENA M, Lloveras B, Tous S, Bogers J, et al
    Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study.
    PLoS One. 2017;12:e0184520.
    PubMed     Abstract available


  410. THEIN HH, Anyiwe K, Jembere N, Yu B, et al
    Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study.
    PLoS One. 2017;12:e0186350.
    PubMed     Abstract available


  411. CHEN J, Cai W, Lin Y, Chen Y, et al
    Patterns and rates of abdominal lymphatic metastasis following esophageal carcinoma.
    PLoS One. 2017;12:e0185424.
    PubMed     Abstract available


  412. CHOI YJ, Lee DH, Han KD, Kim HS, et al
    The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
    PLoS One. 2017;12:e0185778.
    PubMed     Abstract available


  413. HEBBRECHT T, Van Audenhove I, Zwaenepoel O, Verhelle A, et al
    VCA nanobodies target N-WASp to reduce invadopodium formation and functioning.
    PLoS One. 2017;12:e0185076.
    PubMed     Abstract available


  414. SAIGI M, Oliva M, Aliste L, Calvo M, et al
    Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre.
    PLoS One. 2017;12:e0184737.
    PubMed     Abstract available


  415. WILMS T, Khan G, Coates PJ, Sgaramella N, et al
    No evidence for the presence of Epstein-Barr virus in squamous cell carcinoma of the mobile tongue.
    PLoS One. 2017;12:e0184201.
    PubMed     Abstract available


  416. KHATAMI F, Larijani B, Heshmat R, Keshtkar A, et al
    Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer.
    PLoS One. 2017;12:e0184892.
    PubMed     Abstract available


  417. SINGH R, De Sarkar N, Sarkar S, Roy R, et al
    Analysis of the whole transcriptome from gingivo-buccal squamous cell carcinoma reveals deregulated immune landscape and suggests targets for immunotherapy.
    PLoS One. 2017;12:e0183606.
    PubMed     Abstract available


  418. GAL B, Vesely M, Collakova J, Nekulova M, et al
    Distinctive behaviour of live biopsy-derived carcinoma cells unveiled using coherence-controlled holographic microscopy.
    PLoS One. 2017;12:e0183399.
    PubMed     Abstract available


  419. LEXOMBOON D, Karlsson P, Adolfsson J, Ekbom A, et al
    Consumption and direct costs of dental care for patients with head and neck cancer: A 16-year cohort study.
    PLoS One. 2017;12:e0182877.
    PubMed     Abstract available


  420. MEI D, Lv B, Chen B, Xiao S, et al
    All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis.
    PLoS One. 2017;12:e0182835.
    PubMed     Abstract available


  421. HELSEN N, Roothans D, Van Den Heuvel B, Van den Wyngaert T, et al
    18F-FDG-PET/CT for the detection of disease in patients with head and neck cancer treated with radiotherapy.
    PLoS One. 2017;12:e0182350.
    PubMed     Abstract available


  422. LAMPERSKA KM, Kolenda T, Teresiak A, Kowalik A, et al
    Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics.
    PLoS One. 2017;12:e0180265.
    PubMed     Abstract available


  423. CASTAGNOLA P, Gandolfo S, Malacarne D, Aiello C, et al
    DNA aneuploidy relationship with patient age and tobacco smoke in OPMDs/OSCCs.
    PLoS One. 2017;12:e0184425.
    PubMed     Abstract available


  424. SUMI M, Sato S, Nakamura T
    Extranodal spread of primary and secondary metastatic nodes: The dominant risk factor of survival in patients with head and neck squamous cell carcinoma.
    PLoS One. 2017;12:e0183611.
    PubMed     Abstract available


  425. WAN Z, Huang Z, Chen L
    Survival predictors associated with signet ring cell carcinoma of the esophagus (SRCCE): A population-based retrospective cohort study.
    PLoS One. 2017;12:e0181845.
    PubMed     Abstract available


  426. TAKENAKA Y, Kitamura T, Oya R, Ashida N, et al
    Prognostic role of neutrophil-lymphocyte ratio in nasopharyngeal carcinoma: A meta-analysis.
    PLoS One. 2017;12:e0181478.
    PubMed     Abstract available


  427. REID P, Wilson P, Li Y, Marcu LG, et al
    In vitro investigation of head and neck cancer stem cell proportions and their changes following X-ray irradiation as a function of HPV status.
    PLoS One. 2017;12:e0186186.
    PubMed     Abstract available


  428. MEI LL, Wang WJ, Qiu YT, Xie XF, et al
    miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma.
    PLoS One. 2017;12:e0185636.
    PubMed     Abstract available


  429. DOOSTI-IRANI A, Mansournia MA, Rahimi-Foroushani A, Haddad P, et al
    Complications of stent placement in patients with esophageal cancer: A systematic review and network meta-analysis.
    PLoS One. 2017;12:e0184784.
    PubMed     Abstract available


  430. ZHANG S, Hu F, Liang H, Liu Y, et al
    Association between a miRNA-146a polymorphism and susceptibility to head and neck squamous cell carcinoma in Chinese patients: A meta-analysis of 8 case-control studies.
    PLoS One. 2017;12:e0186609.
    PubMed     Abstract available


  431. LUCAS-ROXBURGH R, Benschop J, Lockett B, van den Heever U, et al
    The prevalence of human papillomavirus in oropharyngeal cancer in a New Zealand population.
    PLoS One. 2017;12:e0186424.
    PubMed     Abstract available


  432. KIM A, Ashman P, Ward-Peterson M, Lozano JM, et al
    Racial disparities in cancer-related survival in patients with squamous cell carcinoma of the esophagus in the US between 1973 and 2013.
    PLoS One. 2017;12:e0183782.
    PubMed     Abstract available


  433. SUN X, Chandar AK, Canto MI, Thota PN, et al
    Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.
    PLoS One. 2017;12:e0184962.
    PubMed     Abstract available


  434. FISCHER C, Lingsma H, Klazinga N, Hardwick R, et al
    Volume-outcome revisited: The effect of hospital and surgeon volumes on multiple outcome measures in oesophago-gastric cancer surgery.
    PLoS One. 2017;12:e0183955.
    PubMed     Abstract available


  435. SHE Y, Nong X, Zhang M, Wang M, et al
    Epstein-Barr virus infection and oral squamous cell carcinoma risk: A meta-analysis.
    PLoS One. 2017;12:e0186860.
    PubMed     Abstract available


  436. JANMAAT VT, van Olphen SH, Biermann KE, Looijenga LHJ, et al
    Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0186305.
    PubMed     Abstract available


  437. BAN EZ, Lye MS, Chong PP, Yap YY, et al
    Haplotype CGC from XPD, hOGG1 and ITGA2 polymorphisms increases the risk of nasopharyngeal carcinoma in Malaysia.
    PLoS One. 2017;12:e0187200.
    PubMed     Abstract available


  438. DONG Y, Ochsenreither S, Cai C, Kaufmann AM, et al
    Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis.
    PLoS One. 2017;12:e0187615.
    PubMed     Abstract available


  439. YANG L, Ji Y, Chen L, Li M, et al
    Genetic variability in LMP2 and LMP7 is associated with the risk of esophageal squamous cell carcinoma in the Kazakh population but is not associated with HPV infection.
    PLoS One. 2017;12:e0186319.
    PubMed     Abstract available


  440. NAM SJ, Kwak JY, Moon HJ, Yoon JH, et al
    Large (>/=3cm) thyroid nodules with benign cytology: Can Thyroid Imaging Reporting and Data System (TIRADS) help predict false-negative cytology?
    PLoS One. 2017;12:e0186242.
    PubMed     Abstract available


  441. SKANDARAJAH A, Sunny SP, Gurpur P, Reber CD, et al
    Mobile microscopy as a screening tool for oral cancer in India: A pilot study.
    PLoS One. 2017;12:e0188440.
    PubMed     Abstract available


  442. FUJISHIMA H, Fumoto S, Shibata T, Nishiki K, et al
    A 17-molecule set as a predictor of complete response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer.
    PLoS One. 2017;12:e0188098.
    PubMed     Abstract available


  443. XU J, Hu J, Yu P, Wang W, et al
    Perioperative risk factors for postoperative pneumonia after major oral cancer surgery: A retrospective analysis of 331 cases.
    PLoS One. 2017;12:e0188167.
    PubMed     Abstract available


  444. HE C, Ma J, Jiang Y, Su X, et al
    Associations between RET tagSNPs and their haplotypes and susceptibility, clinical severity, and thyroid function in patients with differentiated thyroid cancer.
    PLoS One. 2017;12:e0187968.
    PubMed     Abstract available


  445. SUN YW, Chen KM, Imamura Kawasawa Y, Salzberg AC, et al
    Hypomethylated Fgf3 is a potential biomarker for early detection of oral cancer in mice treated with the tobacco carcinogen dibenzo[def,p]chrysene.
    PLoS One. 2017;12:e0186873.
    PubMed     Abstract available


  446. SHINOMIYA H, Shinomiya H, Kubo M, Saito Y, et al
    Prognostic value of ALDH2 polymorphism for patients with oropharyngeal cancer in a Japanese population.
    PLoS One. 2017;12:e0187992.
    PubMed     Abstract available


  447. DING W, Liu T, Liang J, Hu T, et al
    Supraglottic squamous cell carcinomas have distinctive clinical features and prognosis based on subregion.
    PLoS One. 2017;12:e0188322.
    PubMed     Abstract available


  448. SUBARNBHESAJ A, Miyauchi M, Chanbora C, Mikuriya A, et al
    Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma.
    PLoS One. 2017;12:e0187092.
    PubMed     Abstract available


  449. GOLBERT L, de Cristo AP, Faccin CS, Farenzena M, et al
    Serum TSH levels as a predictor of malignancy in thyroid nodules: A prospective study.
    PLoS One. 2017;12:e0188123.
    PubMed     Abstract available


  450. SUN C, Han C, Jiang Y, Han N, et al
    Inhibition of GRP78 abrogates radioresistance in oropharyngeal carcinoma cells after EGFR inhibition by cetuximab.
    PLoS One. 2017;12:e0188932.
    PubMed     Abstract available


  451. PANG T, Huang L, Deng Y, Wang T, et al
    Logistic regression analysis of conventional ultrasonography, strain elastosonography, and contrast-enhanced ultrasound characteristics for the differentiation of benign and malignant thyroid nodules.
    PLoS One. 2017;12:e0188987.
    PubMed     Abstract available


  452. ABDALLA Z, Walsh T, Thakker N, Ward CM, et al
    Loss of epithelial markers is an early event in oral dysplasia and is observed within the safety margin of dysplastic and T1 OSCC biopsies.
    PLoS One. 2017;12:e0187449.
    PubMed     Abstract available


  453. SASABE E, Tomomura A, Tomita R, Sento S, et al
    Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
    PLoS One. 2017;12:e0188965.
    PubMed     Abstract available


  454. MITCHELL S, Williams JP, Bhatti H, Kachaamy T, et al
    A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy.
    PLoS One. 2017;12:e0188628.
    PubMed     Abstract available


    January 2016
  455. MURAKAMI S, Verdonschot RG, Kakimoto N, Sumida I, et al
    Preventing Complications from High-Dose Rate Brachytherapy when Treating Mobile Tongue Cancer via the Application of a Modular Lead-Lined Spacer.
    PLoS One. 2016;11:e0154226.
    PubMed     Abstract available


  456. WU MY, He XY, Hu CS
    Tumor Regression and Patterns of Distant Metastasis of T1-T2 Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.
    PLoS One. 2016;11:e0154501.
    PubMed     Abstract available


  457. CHOI J, Kim JW, Keum YS, Lee IJ, et al
    The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic Groups.
    PLoS One. 2016;11:e0154739.
    PubMed     Abstract available


  458. KARTHA VK, Stawski L, Han R, Haines P, et al
    PDGFRbeta Is a Novel Marker of Stromal Activation in Oral Squamous Cell Carcinomas.
    PLoS One. 2016;11:e0154645.
    PubMed     Abstract available


  459. WANG YW, Wu CS, Zhang GY, Chang CH, et al
    Can Parameters Other than Minimal Axial Diameter in MRI and PET/CT Further Improve Diagnostic Accuracy for Equivocal Retropharyngeal Lymph Nodes in Nasopharyngeal Carcinoma?
    PLoS One. 2016;11:e0163741.
    PubMed     Abstract available


  460. PENG XS, Xie GF, Qiu WZ, Tian YH, et al
    Type 2 Diabetic Mellitus Is a Risk Factor for Nasopharyngeal Carcinoma: A 1:2 Matched Case-Control Study.
    PLoS One. 2016;11:e0165131.
    PubMed     Abstract available


  461. ENZENHOFER E, Parzefall T, Haymerle G, Schneider S, et al
    Impact of Sonic Hedgehog Pathway Expression on Outcome in HPV Negative Head and Neck Carcinoma Patients after Surgery and Adjuvant Radiotherapy.
    PLoS One. 2016;11:e0167665.
    PubMed     Abstract available


  462. MAEKAWA N, Konnai S, Okagawa T, Nishimori A, et al
    Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma.
    PLoS One. 2016;11:e0157176.
    PubMed     Abstract available


  463. TSUJIKAWA T, Asahi S, Oh M, Sato Y, et al
    Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET.
    PLoS One. 2016;11:e0155635.
    PubMed     Abstract available


  464. SU W, Liu J, Miles BA, Genden EM, et al
    Adjuvant Radiation Therapy Alone for HPV Related Oropharyngeal Cancers with High Risk Features.
    PLoS One. 2016;11:e0168061.
    PubMed     Abstract available


  465. GROSSI MARCONI D, da Costa Resende B, Rauber E, de Cassia Soares P, et al
    Head and Neck Non-Melanoma Skin Cancer Treated By Superficial X-Ray Therapy: An Analysis of 1021 Cases.
    PLoS One. 2016;11:e0156544.
    PubMed     Abstract available


  466. CIAPPUCCINI R, Aide N, Blanchard D, Rame JP, et al
    Incremental Value of a Dedicated Head and Neck Acquisition during 18F-FDG PET/CT in Patients with Differentiated Thyroid Cancer.
    PLoS One. 2016;11:e0162482.
    PubMed     Abstract available


  467. YANG PY, Miao NF, Lin CW, Chou YE, et al
    Impact of Maspin Polymorphism rs2289520 G/C and Its Interaction with Gene to Gene, Alcohol Consumption Increase Susceptibility to Oral Cancer Occurrence.
    PLoS One. 2016;11:e0160841.
    PubMed     Abstract available


  468. BRENNER B, Sarfaty M, Purim O, Kundel Y, et al
    A Phase Ib/II Study Evaluating the Combination of Weekly Docetaxel and Cisplatin Together with Capecitabine and Bevacizumab in Patients with Advanced Esophago-Gastric Cancer.
    PLoS One. 2016;11:e0157548.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: